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Basic Fibroblast Growth Factor (bFGF) has been shown to modulate the proliferation 
and migration of periodontal cells and angiogenesis at the wound-healing site and 
enhance periodontal regeneration. The aim was to study the distribution of bFGF in 
healing periodontal tissue in a canine model. Sixty experimental roots were 
endodontically treated and extracted from six dogs. The roots were randomly 
distributed into immediate and 1 hour-delayed replantation groups. The observation 
times were ½, 2, 3 and 4 days and non-extraction/replantation teeth served as base line. 
The specimens were fixed, demineralised and the 5µm thick sections were processed 
for immunohistochemical evaluation. Mean percentage of positive cell count and 
intensity score of extracellular matrices as well as qualitative assessments were made. 
These results were analyzed using Kruskal Wallis test and Mann-Whitney U test. In 
PDL, immediate replantation group had higher percentage of positive cell count 
(P=0.02) than delayed replantation group at ½ day time point. In bone, within the 
immediate replantation group, 4 days time group had significantly higher percentage of 
positive cell count (P=0.01) compared to ½ day time group. In cementum, there were 
significant differences between the non-experimental group and 2 days (P=0.01) and 3 
days (P=0.01) immediate replantation group in the extracellular matrix intensity. In 
addition, there were significant differences between the non-experimental group and 
the delayed replantation group at ½ day (P=0.01), 2 days (P=0.01) and 3 days (P=0.00) 
time points in cementum. While comparing the different structures, PDL had higher 
percentage of positive cell count than cementum in ½ day immediate replantation 
group (P=0.01). The cementum cell count was higher than bone cell count in ½ day 
(P=0.00), 2 days (P=0.01), 3 days (P=0.01) immediate replantation groups and also in 
½ day delayed replantation group (P=0.00). In addition the PDL cell count was higher 
 viii
than bone cell count in ½ day (P=0.00), 2 days (P=0.01), 3 days (P=0.00) immediate 
replantation groups and also in ½ day delayed replantation groups (P=0.01). The 
results showed that the bFGF was expressed in cementum, periodontal ligament and 
alveolar bone of the non-experimental group as well as the immediate and delayed 
replanted roots and there were some significant differences among different structures 
and at different time points. The bFGF appeared to play a role in periodontal healing of 
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The tooth is attached to the jaw by specialized supporting apparatus that consists of 
alveolar bone, the periodontal ligament and cementum, all of which are protected by the 
gingiva (Fig1) (Orbans, 1991).   
 
Teeth and their supporting structures can be traumatized in many different ways during 
accidents, falls and playground or sports injury. Relative to other tooth injuries, avulsion is 
the most serious assault to the gingiva, the periodontal ligament and the pulp. Tooth 
avulsion is defined as the removal of tooth from its socket as a result of trauma (Donaldson 
and Kinirons, 2001). It has a reported frequency between 1% and 16% of all traumatic 
injuries to permanent teeth and 7% to 13% of injuries to primary dentition (Andreasen, 
1994).  
 
When a tooth is avulsed, periodontal and pulpal damages occur. As the tooth is separated 
from the socket, the blood supply is cut off from the pulp, leading to pulp necrosis. The 
periodontal ligament from root surface is torn and crushing of the tooth against the socket 
wall during avulsion also results in localized cemental damage (Trope, 2002). When the 
tooth is outside the socket, the pulpal and periodontal cells begin to deteriorate as a result 
of lack of blood supply to the cells (Donaldson and Kinirons, 2001). The pulpal 
consequence of tooth replantation can be either revascularization in immature teeth or 
inflammatory root resorption due to infection of the necrotic pulp, if left untreated. On the 
other hand, the periodontal consequence of replanted tooth is either surface resorption in 




The desired treatment option of such injuries is tooth replantation to its original tooth 
socket. Tooth replantation at the earliest possible time, along with the avoidance of further 
periodontal damage, is crucial to achieve a successful outcome (Pettiette et al., 1997). 
Unfortunately, immediate replantation is not always possible and most avulsed teeth 
experience delayed replantation. Hence, in addition to the injury site, time for which the 
tooth is out of the socket, the storage media and the endodontic protocol have been shown 
to influence the prognosis of the tooth (Trope and Friedman, 1992). 
 
 In the case of immediate replantation, the periodontal ligament cells will maintain their 
viability allowing them to reattach on replantation without causing any more than minimal 
destructive inflammation (Andreasen, 1981). However if excessive drying occurs before 
replantation the damaged periodontal ligament cells will elicit a severe inflammatory 
response over a diffused area on the root surface (Trope, 2002). 
 
After replantation the regeneration of the periodontal attachment is particularly difficult to 
achieve, because of the presence of different kinds of tissue that must be restored to 
produce a functional unit (Howell et al., 1996). The key to tissue regeneration is the 
stimulation of a series of events and cascades at a point, which can result in coordination, 
and completion of integrated tissue formation. Various biological approaches like 
application of growth and differentiation factors, extracellular matrix proteins and 
attachment factors for the promotion of periodontal regeneration have been studied 
(Cochran, 1999). The polypeptide growth factors, a potent biologic mediator, regulating 
numerous activities of wound healing have been suggested for the promotion of 
periodontal regeneration (Terranova et al., 1987).  
 2 
Several growth factors, individually or in combinations have been examined for their 
periodontal regenerative potential in animal models and in clinical trials. The success of 
growth factor therapy depends on their ability to stimulate the cells responsible for the 
regeneration of mineralized and non-mineralized tissues of the periodontium. A 
combination of factors may be the most effective method to achieve periodontal 
regeneration (Lynch, 1994). The factors presently believed to contribute to periodontal 
regeneration include fibroblast growth factor (FGF), platelet derived growth factor 
(PDGF), insulin-like growth factor (IGF), transforming growth factor-beta (TGF-beta) and 
bone morphogenetic proteins (Graves and Cochran, 1994).   
 
In vitro studies conducted by Terranova et al (1989) reported that FGFs could stimulate 
mitogenesis and chemotaxis in PDL cells. There have been at least twenty-three different 
members of the FGF family described so far (Simon et al., 2002). Among these two are 
well characterized, one is acidic fibroblast growth factor (aFGF / FGF-1) and the other is 
basic fibroblast growth factor (bFGF / FGF-2). The two are regulated independently and 
encoded by separate genes but they generally induce similar spectrum of biological 
activities. The bFGF has been found to be 30 times more potent than the other members of 
the family (Howell et al., 1996). 
 
The effect of bFGF on wound healing, angiogensis and periodontal regeneration has been 
studied in previously animal models (Miki et al., 1994, Folkman and Klagsbrun, 1987). 
The proliferation of osteoblasts and bone formation are stimulated by bFGF in organ 
culture (Graves and Cochran, 1994). Studies have shown that the receptors for the basic 
fibroblast growth factor have been expressed on regenerating human PDL cells (Takayama 
et al., 1998). Studies on the effects of bFGF on individual cell types have shown that it can 
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stimulate endothelial cell and periodontal cell migration and proliferation and also 
promotes wound healing (Terranova et al., 1989, Tweden et al., 1989). Based on these 
studies we speculate that the injured periodontal cells may express the bFGF during 
periodontal healing after replantation. 
 
Even though there were numerous studies on bFGF and periodontal regeneration, none of 
these studies dealt with the bFGF expression in replanted avulsed teeth. The aim of the 
current study was to examine the bFGF expression in optimal and delayed replanted teeth. 
The results might provide useful baseline information for better understanding of 
periodontal healing of replanted avulsed teeth. 
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2. Literature Review 
 
2.1 Embryology of the Periodontium 
 
 
In the earliest stage of tooth development, the mesenchymal cells immediately underneath 
the epithelial cap of the enamel organ begin to proliferate and form the dental papilla. The 
dental papilla ultimately gives rise to the dentin and pulp. The cells from the dental papilla 
continue to proliferate and begin to encapsulate the enamel organ to form the dental follicle 
from which the root cementum, periodontal ligament and alveolar bone will eventually 
developed (Bartold and Narayanan, 1998). The periodontal ligament fibroblasts have their 
origins in the dental follicle and begin to differentiate during root development (Ten Cate 
et al., 1971). With continuing apical development of the root, the cells of the dental follicle 
differentiate into cementoblasts to form the cementum lining of the root surface, and this 
subsequently leads to the appearance of periodontal ligament fibroblasts and the formation 
of the periodontal ligament (Grant and Bernick, 1972). During wound healing they are 
derived from ancestral cells in the periodontal ligament and bone (Pitaru et al., 1994). The 
relationship of growth factors with tooth development will be discussed in the later part of 
the literature review.  
 
2.2 Structure of the Periodontium  
 
The periodontium is a connective tissue, covered by epithelium that attaches the teeth to 
the bones of the jaws and provides a continually adapting apparatus for support of the teeth 
during function. It comprises of four connective tissues, two of which are mineralized and 
two are fibrous. The two mineralized connective tissues are cementum and alveolar bone, 
and the two fibrous connective tissues are the periodontal ligament and the lamina propria 
of the gingiva (Fig 2) (Orban’s, 1991). Periodontal tissue is highly cellular, containing 
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fibroblasts, vascular, neural, bone and cemental cells and intercellular substances, which in 
turn contain proteins and polysaccharides (Carranza and Newman, 1998). The primary 
function of the periodontium is support for the teeth, transmission of neural input to the 




Cementum is the thin layer of calcified tissue covering the dentine of the root. It is a highly 
responsive mineralized tissue giving attachment to the collagen fibres of the periodontal 
ligament, maintaining the integrity of the root, helping to maintain the tooth in its 
functional position in the mouth and being involved in tooth repair and regeneration. The 
cementum is avascular and has no innervation. Based on the presence or absence of cells, it 
can be classified as acellular or primary cementum and the cellular or secondary 
cementum. The function of the acellular cementum is for anchorage while the cellular 
cementum is for adaptation and repair (Nanci and Somerman, 2003). 
 
2.2.1.1. Cementoblasts  
 
The distribution of cementoblasts on the tooth surface is similar to the distribution of 
osteoblasts on the bone surface. Cementoblasts appear near the cementum and these cells 
differentiate locally from mesenchymal cells as and when the need for the cells arises 
(Avery, 2000). Cementum formation requires cementoblasts that must be recruited from 
ancestral cementoprogenitor cells. The precise origin of cementoblasts and the molecular 
factors regulating their recruitment and differentiation are unknown (Regan et al., 1999). 
McCulloch et al (1987) reported that progenitor cells may migrate into the periodontal 
ligament from endosteal spaces in the adjacent alveolar bone, and then give rise to both 
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osteoblasts and cementoblasts in mice. On the othe hand, it has also been reported that the 
progenitor cells in the periodontal ligament proliferate and produce differentiated cells 
which can synthesize bone, cementum and the extracellular matrix of the periodontal 
ligament (Melcher, 1980). Sato et al (2004) showed that bFGF enhance the proliferation 
and migration of cementoblasts in the early stages of wound healing by applying bFGF on 




As the cementum deposition progresses, the cementoblasts become entrapped in the 
extracellular matrix they secrete. These entrapped cells are called cementocytes and they 
have a lower secretory activity compared to the cementoblasts (Nanci and Somerman, 
2003). The cementocytes present along with the intrinsic fibers and appears to be involved 
in repair and adaptation (Bartold and Narayanan, 1998). 
 
2.2.1.3. Extracellular Matrix 
 
It is made up of 45% to 50% inorganic hydroxyapatite and 50% collagen and non-
collagenous organic proteins. The non-collagenous proteins include the bone sialoprotein, 
osteopontin, fibronectin, tenascin and proteoglycans (MacNeil et al., 1995, Bronckers et 
al., 1994, MacNeil and Somerman, 1993). McKee et al (1996) demonstrated the presence 
of heparan sulfate proteoglycan (HSPG), osteopontin, osteocalcin, bone sialoprotein, bone 
acidic glycoprotein-75 and albumin in cementum. It has been suggested that proteoglycans 
have a role in the formation of mineralized matrix of the cementum (Bartold and 
Narayanan, 1998). The collagen matrix is composed mainly of Type I and Type III 
collagens (Birkedal-Hansen et al., 1977).  
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 2.2.1.4. Cementum –Dentine Junction 
 
The matrices of dentine and cementum bond together to form a cohesive interface termed 
the cementum-dentine junction (CDJ) (McKee et al., 1996). It has also been suggested that 
CDJ is not a clear delineation between structures where the extracellular matrix fibrils in 
dentine and cementum intermingle (Nanci and Somerman, 2003). A granular-appearing 
area called the granular layer of Tomes can be seen just below the surface of the dentine 
where the root is covered by the cementum. A progressive increase in these granules 
occurs from the cemento-enamel junction to the apex of the tooth. During root 
development, mineralization of mantle dentine occurs internally and does not reach the 
surface until it intermingles with cementum (Nanci and Somerman, 2003).  
 
2.2.2. Periodontal Ligament 
 
 
The PDL is that soft, specialized connective tissue situated between the cementum 
covering the root of the tooth and the bone forming the socket wall. Its principal function is 
supporting the teeth in the socket and at the same time permitting to withstand the 




The healthy, functioning periodontal ligament consists of fibroblasts, epithethelial cells and 
undifferentiated mesenchymal cells. An important cellular constituent of the PDL is the 
undifferentiated mesenchymal cell or progenitor cell and these cells have a perivascular 
location and have been demonstrated to be a source of new cells for the PDL (Nanci and 
Somerman, 2003). The major cell in the periodontal ligament is the fibroblast, which is 
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responsible for producing the collagens, non-collageneous proteins and preteoglycans of 
this tissue (Smalley et al., 1984). These cells rest with their long axes parallel to the 
collagen fibers, and synthesize and degrade collagen. These cells have been studied 
extensively for the production and turnover of the extracellular matrix of the periodontal 
ligament (Hou and Yaeger, 1993). Fibroblasts may be capable of both synthesis and 
resorption. Fibroblasts in various stages of differentiation and their progenitors are found 
in the periodontal ligament. The fibroblasts have the ability to simultaneously synthesize 
and degrade collagen, a process essential to the periodontal ligament’s high turnover of 
collagen. Collagen resorbing fibroblasts are found in normal functioning periodontal 
ligament and their presence indicates resorption of fibers occurring during physiologic 
turnover or remodeling of periodontal ligament (Orban’s, 1991).  
 
The primary function of the activated fibroblast in wound healing is to produce collagen, 
elastin and proteoglycans. However, progression factors such as insulin-like growth factor-
1, epidermal growth factor and other plasma factors are necessary to stimulate the 
fibroblast to undergo replication. Before this, fibroblast must be made competent by the 
“competence factors” such as platelet derived growth factor (PDGF), fibroblast growth 
factor (FGF) and calcium phosphate precipitates (Morgan et al., 1992). Terranova et al 
(1989) reported that bFGF can stimulate the mitogenesis and chemotaxis of PDL 
fibroblasts. 
2.2.2.2. Mast Cells 
 
 
Mast cells play a role in the inflammatory reaction and they have been shown to 
degranulate and respond to antigen-antibody formation on their surface. Occasionally mast 
cells may be seen in the healthy periodontal ligament. The release of mast cell histamine 
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into the extra cellular environment causes proliferation of endothelial cells and 
mesenchymal cells.  Consequently mast cells may play an important role in regulating 




Macrophages are the important defense cells and they have phagocytic activity and 
mobility. They are found in the ligament and are predominantly located adjacent to blood 
vessels. They engulf bacteria, dead cells and foreign bodies. Macrophages, lymphocytes, 
leukocytes and plasma cells may also appear in the periodontium when it is stressed by 
disease (Avery, 2000). Macrophages are one of the sources for growth factors such as FGF, 
PDGF, IL-1/TNF. And also produce fibronectin during wound healing (Andreasen, 1994). 
2.2.2.4. Epithelial Rests of Malassez 
 
The epithelial cells in the PDL are remnants of Hertwig’s epithelial root sheath, known as 
the epithelial cell rests of Malassez. They occur close to the cementum as clusters or 
strands of cells (Nanci and Somerman, 2003). There is some evidence that secretory 
products from the epithelial cell rests could direct cellular events during cementogenesis 
(Berkovitz et al., 2002). 
 
2.2.2.5. Extracellular Matrix 
 
The extracellular matrix of periodontal ligament contains numerous collagen mainly Type I 
collagen and non-collagenous proteins like fibronectin, elastin, osteonectin, osteopontin 
and proteoglycans and they are produced by the periodontal ligament fibroblasts 
(Ramakrishnan et al., 1995). The extracellular matrix can regulate cellular function by 
mediating the cell adhesion and binding of growth factors. Many molecules are present in 
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extracellular matrix that include collagens, proteoglycans, elastin, fibronectin, osteopontin, 
laminin, vitronectin, thrombospondin, fibrinogen and von willebrand factor (McAllister et 
al., 1990). A variety of proteins and other extracellular matrix components control cell 
migration, adhesion and cellular functions (Cochran and Wozney, 1999). The 
glycosaminoglycan components in the periodontal ligament include heparan sulfate, 
chondroitin sulfate, dermatan sulfate and hyaluronate (Gibson and Pearson, 1992). The 
adhesion of cells to the extracellular matrix via integrins or proteoglycans provides cells 
with anchorage, directed migration and signals for governing cell function. The binding of 
growth factors to the matrix allows for subsequent interaction with cells. The ability to 
localize and concentrate growth factors with receptor mediated cell binding, helps in 
organization, modulation and functions of the tissue (Mariotti, 1993). The bFGF is present 
in periodontal tissues bound to heparin or heparan sulfate residues in the extracellular 
matrix (Tweden et al., 1989). 
 
2.2.3. Alveolar Bone 
 
The alveolar bone is the bone lining the sockets of the teeth. It comprises of an inner and 
outer components and it is perforated by many foramina which transmits nerves and 
vessels (Nanci and Somerman, 2003).The alveolar bone is subjected to continual and rapid 
remodeling associated with tooth eruption and functional demands of mastication (Sodek 
and McKee, 2000). The bone that is directly lining the socket is referred to as bundle bone. 
Embedded within this bone are the extrinsic collagen fiber bundles of the PDL. The bundle 
bone thus provides attachment for the PDL fiber bundles that insert into the alveolar bone 




2.2.3.1. Osteoblasts  
 
The osteoblasts covering the periodontal surface of the alveolar bone constitute a modified 
endosteum and not a periodontium. A periosteum can be recognized by the fact that it 
comprises at least two distinct layers, an inner cellular or cambium layer and an outer 
fibrous layer. Usually the cellular layer is present on the periodontal surface of the alveolar 
bone. Osteoblasts are located along the surface of the alveolar bone in various stages of 
differentiation and are able to multiply (Orban’s, 1991). The bFGF increase osteoblast 
proliferation, although they do not directly increase collagen production by differentiated 
osteoblasts (Graves et al., 1994). In vitro studies showed that bFGF is highly mitogenic for 
preosteoblasts and osteoblasts. But on differentiated osteoblasts the effect of bFGF are 




Osteocytes are lying within the bone matrix and they are ‘entrapped’ osteoblasts. 
Osteoblasts become deeply situated and less active with continued bone formation. 
Osteocytes are in communication with osteoblasts at the surface (Berkovitz et al., 2002).  
 
2.2.3.3. Extracellular Matrix  
 
The extracellular matrix of the alveolar bone consists of type I collagen which makes up 
the bulk of the sharpey’s fibers (Bartold and Narayanan, 1998). In bone, chondroitin 
sulphate and heparan sulfate proteoglycans are present with osteonectin, osteopontin, bone 
sialoprotein II, thrombospondin, osteocalcin, fibronectin (Berkovitz et al., 2002). Bone 
matrix is a rich source of growth factors like FGF, PDGF, TGF-ß and bone morphogenetic 
protein (Nakae et al., 1991).  
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2.3. Periodontal Healing of Replanted Tooth 
 
 
Immediately after replantation, a coagulum is found between the two parts of the severed 
periodontal ligament. The line of separation is most often situated in the middle of the 
periodontal ligament. Proliferation of connective tissue cells soon occurs, and after 3 to 4 
days, the gap in the periodontal ligament is obliterated by young connective tissue. After 
two weeks the separation line in the periodontal ligament is healed and collagen fibers are 
seen extending from cemental surface to alveolar bone (Andreasen, 1994). 
 
 2.3.1. Complications of Replanted Tooth 
 
Replantation of the avulsed tooth often will lead to pulpal and periodontal complications. 
Pulp pathology includes pulpal necrosis and internal resorption. And the periodontal 
reactions include healing with normal periodontium, healing with ankylosis (replacement 
resorption) with or without inflammatory resorption (Andreasen, 1994). 
 
2.3.1.1. Pulpal Pathology 
 
Ohman, (1965) examined 85 immediately replanted matured human teeth histologically 
and found extensive pulpal change as early as the third day after replantation. The most 
severe damage was usually observed in the coronal part of the pulp. Signs of healing were 
seen within two weeks after replantation. Proliferating mesenchymal cells and capillaries 
gradually replaced damaged coronal pulp tissue. In the border zone between vital and 
necrotic tissue, neutrophils and round cells were present in most of the cases. More 
advanced healing was found in long-observed cases. Regenerating nerve fibers were 
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observed after one month. Severe primary pulpal damage was more often found in teeth 
with completed root formation than in those with an open apex.  
 
Also microangiographic studies in dogs showed ingrowth of new vessels 4 days after 
replantation. After 10 days vessels were seen in the apical half and after 30 days in the 
entire pulp (Skoglund et al., 1978). 
 
2.3.1.2. Periodontal Pathology 
 
Many studies have been done on the periodontal healing after replantation of avulsed or 
extracted tooth.  Four different types of healing patterns of periodontal ligament were 
observed histologically. They were healing with a normal periodontal ligament, surface 
resorption, ankylosis (replacement resorption) and inflammatory resorption (Andreasen 
and Hjorting-Hansen, 1966). 
2.3.1.2.1. Healing With Normal Periodontium  
 
 
Histologically, this is characterized by complete regeneration of periodontal ligament, 
which usually takes about 2-4 weeks to complete. This type of healing occurs only if the 
innermost cell layers along the root are vital. This type of healing will probably take place 
under clinical conditions, as trauma will result in at least minimal injury to the innermost 
layer of the periodontal ligament, leading to surface resorption (Andreasen, 1981).  
2.3.1.2.2. Surface Resorption 
 
 
This type of healing is histologically by localized areas along the root surface, which show 
superficial resorption lacunae repaired by new cementum. This condition is presumably 
representing localized areas of damage to the periodontal ligament or cementum, which is 
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healed by periodontal ligament derived cells. In contrast with other resorption surface 
resorption is self-limiting and new cementum formation is seen. Since they are small in 
size, surface resorptions are not usually revealed on radiographs (Andreasen, 1980, 1981). 
  
2.3.1.2.3. Replacement Resorption (Ankylosis) 
 
 
Ankylosis is the fusion of the alveolar bone and the root surface and histologically seen 
after two weeks of replantation (Andreasen, 1980). Absence of vital periodontal ligament 
on the root surface appears to be the cause of replacement resorption (Lindskog et al., 
1985). Replacement resorption develops in two different directions, depending upon the 
extent of damage to the periodontal ligament covering the root: either progressive 
replacement resorption, which gradually resorbs the entire root, or transient replacement 
resorption, in which already established ankylosis later disappears (Andreasen, 1981). 
Progressive resorption is always elicited when the entire periodontal ligament is removed 
before replantation or after extensive drying of the tooth before replantation (Andreasen, 
1981). It is assumed that the damaged periodontal ligament is repopulated from adjacent 
bone marrow cells, which have osteogenic potential and consequently form an ankylosis. 
Radiographically it is characterized by disappearance of the normal periodontal space and 
continuous replacement of root substances with bone. Clinically the ankylosed tooth is 
immobile (Andreasen, 1981). 
 
Inflammatory resorption is seen as bowl shaped cavities in cementum and dentin 
associated with the inflammatory changes in the adjacent periodontal tissues (Andreasen, 
1975).  The inflammatory reaction in the periodontium consists of granulation tissue 
formation with numerous lymphocytes, plasma cells, and polymorphonuclear leukocytes. 
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The inflammation may be due to necrosis of the pulp or due to remnants of the pulp with or 
without infection. Radiographically, it can be seen as loss of root substance with adjacent 
radiolucency.  The pathogenesis of inflammatory resorption can be minor injuries to the 
periodontal ligament and/or cementum due to trauma or contamination with bacteria 
induce small cavities on the root surface, presumably in the same manner as in surface 
resorption (Andreasen, 1981). The radiographic sign of inflammatory reaction can be 
demonstrated as early as 2-3 weeks after replantation. Clinically the replanted tooth is 
loose and extruded (Andreasen and Hjorting-Hansen, 1966). 
 
2.3.2. Factors Affecting Periodontal Healing 
 
 
Recent studies demonstrated that the storage media, more than the extra-alveolar period 
determines the prognosis. Even prolonged storage in saline or saliva did not significantly 
affect healing, while even short drying periods have adverse effects (Andreasen, 1981). 
 
2.3.2.1. Extra Oral Dry Period 
 
Andersson and Bodin, (1990) found that there was no resorption in teeth replanted before 
10 minutes of extraoral dry period and all the teeth replanted within 10-15 minutes 
exhibited resorption. Cvek et al (1974) reported ankylosis of 60% of the teeth, replanted 
after 30 minutes of extraoral dry period and only 13% of teeth that were replanted before 
15 minutes.  Studies of Blomlof et al (1983) showed, after one-hour dry storage no viable 
human periodontal ligament cells were seen and there was extensive root resorption 
present on all surfaces of monkey teeth. Andreasen and Kristerson, (1981) demonstrated 
that extended dry storage of 60-120 minutes, leads to ankylosis in monkeys. Trope and 
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Friedman, (1992) observed that after one hour of dry storage, there was a high incidence of 
replacement resorption in dogs. 
 
Soder et al (1976) examined the number of viable cells at 0, 5, 15, 60 and 120 minutes of 
extra oral dry period in human and monkey teeth using trypan blue staining method. He 
demonstrated a monolayer of cells that are able to multiply at 0 minutes, 34% of non-
viable cells after 5 minutes, 63% non-viable cells after 15 minutes. He suggested that 60 
minutes is the critical time period when severe cell damage occurs and after 120 minutes 
there were no more viable cells. Gamson et al (1992) observed a decrease in cell viability 
after 20 minutes of dry storage time, which decreased further after 30 minutes and only a 
few viable cells were left after 45 minutes in humans. Blomlof et al (1983) also found no 
viable cells after 1 hour in monkey teeth. Loe and Waerhaug, (1961) found complete 
necrosis of periodontal ligament after 2 hours dry storage of monkey and dog’s teeth. 
 
2.3.2.2. Storage Media 
 
Studies have shown that different storage medias such as saliva, saline, milk, tap water, 
culture media, Hank’s Balanced Salt Solution (HBSS), and ViaSpan can be used for 
maintaining the viability of periodontal ligament. Blomlof and Otteskog, (1980) compared 
the effect of milk and saliva on human periodontal ligament cells. The result of this study 
demonstrated that most of the periodontal ligament cells were viable after prolonged 
storage in milk. Blomlof et al (1981) examined the effect of storage media with different 
ionic strengths and osmolalities on human periodontal ligament cells and they concluded 
that the osmolality of milk, being within physiologic limits, makes it a more suitable 
storage medium than hypotonic saliva for storage of periodontal ligament cell cultures.  
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Hiltz and Trope, (1991) compared the effect of storage in milk, HBSS and ViaSpan on the 
vitality of human lip fibroblasts at times ranging from 2 to 168 hours. They found that 
ViaSpan was the most effective storage medium at all observation periods and even at 168 
hours still had 37.6% vital cells present.  Ashkenazi et al (2000) compared the 
effectiveness of HBSS, Culture medium, alpha-minimal essential medium (α-MEM) and 
ViaSpan as a storage media. The results concluded that the culture medium, followed by 
the HBSS and the ViaSpan, are the most effective storage media for preserving the 
viability, mitogenicity and clonogenic capacity of periodontal ligament fibroblasts after 
storage of up to 24 hours, and α-MEM was the least effective medium for preserving these 
functional abilities. This is attributed to its lowest proliferative capacity compared to other 
tested media.   
 
2.3.2.3. Socket Environment  
 
Besides the tooth condition, Trope et al (1997) demonstrated that the socket environment 
also played an important role in periodontal healing using dog model. They found that the 
rate of replacement resorption increased significantly with increase in the socket age. In 
this study they extracted endodontically treated dog’s teeth were stored in ViaSpan for 6 
hours and replanted into 6, 48 or 96 hours sockets. Controls included teeth extracted and 
replanted immediately, 48 hour stored teeth replanted into 48-hour sockets and 96 hour 
stored teeth replanted into 96-hour socket. The best results were obtained when the teeth 
were replanted immediately. For the teeth stored in ViaSpan for 6 hours, complete healing 
decreased significantly as the age of the socket increased. In addition the rate of 
replacement resorption increased significantly with increasing socket age.  This study 




2.4. Wound Healing 
 
2.4.1. Phases of Wound Healing 
 
 
The process of wound healing is divided into 3 phases, inflammation, proliferation and 
remodeling (Kanzler et al., 1986). It is however a continuous process in which the 
beginning of one phase and the end of another cannot be clearly defined and there is 
considerable overlap between the phases. 
 
2.4.1.1. Inflammation (Substrate) Phase 
 
Injury results in bleeding and the enzymatic activation of the clotting cascade, the 
complement cascade and the kinin cascade; activation of plasminogen and the aggregation 
and the activation of platelets (Steenfos, 1994). A secondary vasodilatation would increase 
capillary permeability, chemo attraction and vasoconstriction. Platelets are the first cells to 
enter the wound, during this stage. The α-granules within the platelets contain cytokines 
and polypeptide growth factors that promote healing (Francis, 1999). The activated 
platelets release PDGF and TGF-β that stimulates the migration of macrophages, 
neutrophils and lymphocytes. These immediate events are sometimes referred to “the 
coagulation phase” (Steenfos, 1994). 
 
Neutrophils are the first leukocytes to enter the wound. These neutrophils serve several 
functions like amplifying the inflammatory response via tumor necrosis factor-alpha (TNF-
α) and interleukins, help to control local bacterial contamination and prevent infection. The 
neutrophils also remove damaged and denatured extracellular matrix components and 
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debride devitalized tissues. The neutrophil response peaks 24 hours after the injury 
(Jackson, 1963). Monocytes are the next cells to enter the wound, attracted by bacterial 
products and extracellular matrix breakdown products along with TGF-β, which is secreted 
by platelets, neutrophils, and monocytes (Francis, 1999). 
 
The platelets, neutrophils and moncytes amplify and control the immune response. 
Monocytes are activated into macrophages, which destroy bacteria and further debride the 
devitalized tissue. Macrophages also provide a prolonged and abundant supply of growth 
factors, which modulate the healing response. The growth factors such as bFGF, PDGF 
and TNF which are released by the macrophages stimulate a further influx of white cells 
and fibroblasts. Active macrophages persist in the wound for about 5 days. The growth 
factors such as bFGF and VEGF stimulate endothelial cells, which causes angiogenesis. 
Later the lymphocytes enter the wound area and they too secrete growth factors and 
cytokines (Steenfos, 1994).  
 
2.4.1.2. Proliferation (Fibroplasia) Phase 
 
This phase is predominated by cellular proliferation and extracellular matrix deposition. 
Stimulated by the released growth factors, fibroblasts and endothelial cells migrate into the 
wound to form granulation tissue. The fibroblasts have a number of receptors for growth 
factors and they secrete a number of growth factors and extracellular matrix molecules 
(Cornelissen et al., 1999). In vitro studies showed that bFGF exposure induced fibroblasts, 
endothelial cells and vascular smooth muscle cells to proliferate (Gospodarowicz and 
Moran, 1975). Fibroblast proliferation at the wound site is followed by collagen and non-
collagen matrix protein synthesis and deposition. As collagen is produced within the 
wound, the healing tissue regains integrity and tensile strength. Angiogenesis also occurs 
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as endothelial cell proliferation coordinates with capillary budding and new blood vessel 
formation. Epithelial cell migration and proliferation are usually complete at this phase of 
healing for primarily closed wounds (Francis, 1999).  
 
2.4.1.3. Remodeling (Scarring) Phase 
 
The final and longest phase in the wound healing process entails the dynamic remodeling 
of collagen and the formation of mature scar. Remodeling phase is responsible for the gain 
in strength of the mature scar because of the structural modification of collagen (Squier 
and Kremenak, 1982). Full maturation of a wound may take up to a year as the 
extracellular matrix is remodeled and as hypercellularity and hypervascularity recede. The 
role of growth factors in the formation of scar tissue is not fully understood (Steenfos, 
1994). Davidson et al (1999) showed increased granulation tissue formation in 
subsequently implanted polyvinyl alcohol sponges after injection with bFGF. The bFGF 
has also been shown that it stimulates the production of extracellular matrix components 
such as collagen, proteoglycan and fibronectin during wound healing (Vlodasky et al., 
1983). 
 
2.4.2. Healing of Extracted Tooth Socket 
 
The healing of an extraction wound does not differ much from the healing of other wounds 
of the body except as it is modified by the anatomic situation, which exists after the 






2.4.2.1. Inflammation Phase  
 
After extraction the inflammatory phase ensues. The blood filling the socket coagulates, 
red blood cells being entrapped in the fibrin meshwork and the ends of the torn blood 
vessels in the periodontal ligament become sealed off. Within the 24-48 hours after 
extraction, the principal alterations such as vasodilatation and engorgement of the blood 
vessels in the remnants of the periodontal ligament occur (Shafer, 1983). During 
inflammation the mobilization of leukocytes to the immediate area around the clot occurs 
(McMillan, 1986). 
 
2.4.2.2. Proliferation Phase 
 
Organization of the clot by the proliferation of fibroblasts from the socket wall occurs on 
the second and third day of the proliferation phase. Numerous growth factors such as 
PDGF, bFGF, TNF, cytokines, chemokines and fibronectin are released by macrophages 
and lymphocytes on the second day. Platelets provide mitogens and chemoattractants for 
fibroblasts (Trowbridge, 1997). After three days the proliferation of fibroblasts from the 
remnants of periodontal ligament is evident. And these fibroblasts have begun to grow into 
the clot around the entire periphery (Mangos, 1941). In proliferation phase the growth 
factors such as bFGF, TGF-β stimulate fibroblasts and endothelial cells, which divide and 






2.4.2.3. Remodelling Phase 
 
In the remodeling phase, the organization of the clot is progressing most rapidly. Very 
young trabeculae of osteoid or uncalcified bone are forming around the entire periphery of 
the wound from the socket wall (Shafer, 1983).  
 
Claflin, (1936) compared human and dog autopsy specimens and found that extraction 
wound healing was significantly slower in the humans than in the dogs. For example 
healing of extraction wound nine or ten days old in a dog was equivalant to healing in a 
three week old human extraction wound, and 8 week old extraction wound in the dog was 
as well healed as three and one half month old extraction wound in man. The repair of the 
epithelium and submucosa in humans takes almost twice as long in dogs and the time for 
the complete filling of the socket with bone about three times as long (Mangos, 1941). 
Takayama et al (1997) revealed that bFGF induced proliferation of PDL cells but inhibited 
the alkaline phosphatase activity. The bFGF could also abrogate the synthesis of type I 
collagen in PDL. In addition, Hurley et al (1993) reported that bFGF inhibits the gene 
expression of type I collagen and collagen synthesis in bone. These results suggest that 




Wound healing angiogenesis (WHA) plays a critical role in successful wound repair. 
Monocytes / macrophages produce many locally active growth factors such as basic 
fibroblast growth factor which could influence WHA. Morphology and chronology of 
WHA in a collagen sponge show that the process begins with margination of leukocytes on 
the venular side of the microcirculation and post capillary venules between 6 and 24 hours 
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after wounding. Forty-eight hours after wounding the venular capillaries and post-capillary 
venular endothelium become hypertrophic and the first capillary buds are seen coming 
from the same vessels. These buds continue to grow and increase in number in 3 days. 
After 7 days, the hairpin configuration is seen, establishing a new capillary loop, and new 
buds continue to grow from the hairpin loop (Burger et al., 1983). 
 
The bFGF has been shown to be angiogenic in vitro in a number of studies. In vitro studies 
demonstrated that fibroblast growth factor stimulates capillary endothelial cell (CEC) 
proliferation; CEC protease synthesis and CEC tube formation (Klagsbrun and Vlodavsky, 
1988).  In an in vitro rat aorta ring model, addition of bFGF increased both the length and 
number of micro vessels sprouting from the explants and a reduction in angiogenesis 
occurred after neutralizing bFGF antibodies were added (Thompson et al., 1991). In a 
human cornea organ culture wound healing model, addition of bFGF shortened the wound 
healing time and increased corneal endothelial cell migration at the wound site (McNeil et 
al., 1989). 
 
2.4.4. Rationale for the Selection of Time Groups 
 
 
To observe the presence of baseline bFGF in normal periodontal tissue, the non-
experimental teeth from each animal were included in the current study. Literatures have 
suggested that the healing in human proceeds slower than in dogs. The repair of the 
epithelium and submucosa takes almost twice as long, while the time for the complete 
bone fill of extraction socket takes about three times as long in human compared to the 
dogs (Mangos, 1941, Claflin, 1936).  
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Studies on healing of extraction sockets in dogs showed the presence of torn periodontal 
ligament on the socket wall with hemorrhage and coagulation accumulate within the socket 
(Mangos, 1941, Claflin, 1936). It was shown that, within 24 hours of wound healing, 
platelets degranulate and release growth factors. The number of neutrophils reaches a peak 
by the end of first day (Trowbridge, 1997). This was extrapolated to time with 12 hours in 
dogs (Claflin, 1936). Macrophages are the next major source of growth factors that start 
migrating into the wound on the second and third day. The growth factors secreted by 
macrophages stimulate the fibroblasts and endothelial cells and the angiogenesis begins 
(Andreasen, 1994). Granulation tissue progressively invades the wound space in human on 
the third day (Kumar and Robbins, 2002) and endothelial cells begin to migrate into the 
wound site (Trowbridge, 1997).  Organization of the clot by fibroblastic proliferation 
occurs within the socket wall on the second and third day in dogs. Osteoclasts are found at 
the crest of the bone and portion of the PDL left in the socket undergo hyaline 
degeneration (Mangos, 1941, Claflin, 1936).  Approximately after 72 hours, inflammatory 
reaction decrease and fibroblasts migrate into the wound and they replicate in response to 
the growth factors and cytokines released during the early phases of wound healing. These 
fibroblasts help to deposit the collagen. These endothelial buds continue to grow and 
increase in number at 3 days (Trowbridge, 1997). After 5 days in humans there is maximal 
neovascularization (Kumar and Robbins, 2002). In about 7 days (extrapolated in dogs as 4 
days), the hairpin configuration is seen, establishing a new capillary loop, and new buds 
continue to grow from the hairpin loop (Burger et al., 1983). Based on these studies, the 






2.5. Growth Factors 
 
2.5.1. General Information 
 
Growth factors can be defined as signaling peptides that act through specific cell surface 
receptors and cause paracrine or autocrine stimulation, or both, of cell proliferation and 
migration (Steenfos, 1994). Growth factors are cellular products that are released or 
activated whenever cell division is needed. This action typically occurs during wound 
healing or tissue regeneration (Graves et al., 1994). Growth factors are biological 
mediators that play a fundamental part in the complex wound healing events that control 
tissue repair and remodeling (Clark and Henson, 1988). Growth factors secreted by 
platelets and activated macrophages have been postulated to play numerous roles in repair 
of tissue injury and development of vascular diseases. In vitro, these growth factors can 
stimulate cell proliferation, cell migration, and changes in extracellular matrix composition 
of specific target cells (Tweden et al., 1989).  
 
2.5.2. Types of Growth Factors  
 
Several growth factors, as single agents or in combinations, have been examined for their 
periodontal regenerative potential in animal models and in clinical practice (Cochran and 
Wozney, 1999). Periodontal regeneration most likely reflects the combined effect of more 
than one growth factor. Based on studies, growth factors that are likely to be important in 
periodontal regeneration are FGF, PDGF, insulin-like growth factor (IGF), vascular 
endothelial growth factor (VEGF), TGF-β, and BMPs (Cochran and Wozney, 1999, 
Giannobile, 1996, Howell et al., 1996, Graves and Cochran, 1994). This list is based on the 
capacity of these factors to stimulate cells, which participate in periodontal regeneration in 
animal studies. A combination of these factors may be the most effective method to 
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achieve periodontal regeneration (Lynch, 1994).  Among these growth factors, the 
fibroblast growth factor displays a broad spectrum of survival activities on a wide variety 
of mesoderm and neuroectoderm-derived cells and has a high efficacy of angiogenesis 
(Ledoux et al., 1992).  
 
2.5.3. Mechanism of Action 
 
Growth factors may act locally or systemically to affect the growth and function of cells in 
several ways. Growth Factors may act in autocrine fashion, where the growth factors affect 
the cells that produce them or more commonly in a paracrine fashion, in which the 
production of a growth factor by one cell type affects the function of a different cell type 
(Cochran and Wozney, 1999). The presence of growth factor receptors on target cell 
surface is a prerequisite for the growth factor to have an effect. The receptor is a protein 
and it has an extracellular site that binds to the growth factor. A signal is then transmitted 
through the transmembrane site into the intracellular site, at which point tyrosine kinase is 
activated. The signal reaches nuclear DNA, through intracellular pathways and activates 
certain gene transcription which leads to production of the target protein. This results in 
cellular division and proliferation, or both. The effect of a growth factor depends both on 
its concentration and the sensitivity of the receptor (Steenfos, 1994).   
 
2.5.4. Growth Factors and Development of Tooth 
 
The development of organs is highly ordered following a pathway of initiation, 
morphogenesis, and differentiation. Cell differentiation and organ development continue to 
be controlled by locally secreted molecules that provide a specific instructional signal to 
target cells. Among these signals, growth factors, cell surface glycoproteins, and 
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components of the extracellular matrix appear to be prime candidates for governing 
developmental processes.  The presence of numerous growth factors has been reported at 
specific stages of growth and development. During odontogenesis, the bone morphogenetic 
proteins (BMPs), fibroblast growth factor (FGF), transforming growth factor- β (TGF-β), 
and platelet-derived growth factor (PDGF), epidermal growth factor (EGF) and growth 
hormone were differentially expressed according to the stage of development, 
morphogenesis, and cell differentiation (Young, 1995). The FGFs also comprise a group of 
growth factors that have a variety of roles. FGF appears in the mesenchyme of developing 
teeth at the late bud stage and persists through late bell stage (Wilkinson et al., 1989). The 
expression patterns of FGF-3, -4, -7, -8, -9, -10, and -20 have been reported during tooth 
development. These FGFs fall into two categories, FGF-3, -7, -10 are expressed in 
overlapping patterns in the dental mesenchyme. The expression of FGF-4, -8, -9 and -20 
show overlapping expression patterns in the signaling centers of the dental epithelium 
(Thesleff and Mikkola, 2002).  
  
2.5.5. Growth Factors and Periodontal Healing 
 
Periodontal regeneration is the reconstitution of the lost supporting tissues, including 
alveolar bone, cementum, periodontal ligament and gingival attachment. The periodontal 
components need to be coordinated and integrated in order for regeneration to occur.  
Healing following injury involves a series of well-orchestrated cell-cell and cell-
macromolecular interactions (Giannobile, 1996). Apart from the inflammatory cells, 
periodontal regeneration involves several cell types: fibroblasts for soft connective tissues, 
cementoblasts for cementogenesis, osteoblasts for bone, endothelial cells for angiogenesis 
and epithelial cells for epithelium (Pitaru et al., 1994). The cellular events during 
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periodontal healing consist of events such as cell chemotaxis, proliferation, differentiation 
and formation of extracellular matrix (Howell et al., 1996, Graves and Cochran, 1994).  
 
 A variety of molecules participate in regulation of processes involved in periodontal 
regeneration. These substances can be divided into three types based on their action: a) 
growth factors and other inflammatory mediators, including cytokines, lymphokines, and 
chemokines; b) adhesion molecules, such as fibronectin and laminin; and c) matrix 
components such as collagens, proteoglycans and hyaluronan.  
 
The first group of molecules (growth factors) regulates the migration and proliferation of 
cells during inflammation and wound repair (Matsuda et al., 1992). These growth factors 
are usually pleiotropic in their action, and their effects depend upon many factors, 
especially the nature of the extracellular matrix. The origins of these growth factors may be 
from the circulation, or produced locally by cells residing in the tissue matrix (Bartold and 
Narayanan, 1998). Selvig et al (1994) suggested that growth factors may facilitate and 
perhaps enhance periodontal regeneration by stimulating mesenchymal cells to form new 
collagen, bone and cementum. The use of polypeptide growth factors that function as 
potent biologic mediators regulating numerous activities of wound healing has been 
suggested for the promotion of periodontal regeneration (Lynch et al., 1989, Terranova et 
al., 1987). 
 
Adhesion molecules localize cells to required sites and may be specific to certain cell types 
or non-specific in their interactions. Specific promotion of attachment is likely to be a 
factor that determines whether recruitment of the needed cell types occurs. The absence of 
the appropriate molecule or cell can be expected to affect the course of healing. There is 
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substantial evidence indicating that cytokines affect adhesion molecules and that adhesion 
molecules can regulate the cellular expression of cytokines (O’Neal et al., 1992). Many of 
the adhesive molecules associated with regulation of cell response to cytokines are related 
to the integrin family (Milam et al., 1991). The periodontal ligament contains fibronectin 
and it is widely distributed between cross-striated collagen fibrils in the microfibrillar 
network and in the pericellular matrix of vascular elements in the blood (Zhang et al., 
1993).  
 
Matrix components such as collagens and proteoglycans are necessary for structural and 
physiologic integrity of the new tissue and these are also needed for other functions, 
particularly for cell differentiation (Bartold and Narayanan, 1998). The major collagen of 
the periodontal ligament extracellular matrix is type I collagen. Anti-collagen type I 
antibodies localize this collagen uniformly throughout the tissue on collagen fibrils, 
especially in major cross-striated Sharpey’s fibers that enter cementum. These fibers are 
codistributed with type III, V, and VI collagens (Bartold and Narayanan, 1998). The 
glycosaminoglycan components found in the periodontal ligament include hyaluronate, 
heparan sulfate, dermatan sulfate (Gibson and Pearson, 1992).These components are 
closely associated with cementoblasts and they are lightly distributed through out the 
cementum matrix. This suggests the role of proteoglycans in the formation of the 
mineralized matrix of cementum (Bartold et al., 1990). Hyaluronan is important in tissue 
hydration, aggregation with other matrix components, cell surface-matrix interactions, cell 
migration, tissue development, inflammation, and wound healing (Laurent and Fraser, 
1992). Clinical application of these factors was assumed to be useful in periodontal 
regenerative procedures (Rutherford et al., 1992).  
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The success of growth factor therapy depends on the ability of growth factors to stimulate 
the cells responsible for the regeneration of mineralized or non-mineralized tissues that 
comprise the periodontium (Howell et al., 1996). Growth factors initiate many of the 
events associated with the orderly turnover, repair and regeneration of periodontal tissues. 
The corresponding receptors are thus of fundamental importance in maintaining 
periodontal integrity and mediating periodontal wound healing but their expression in 
human gingiva, in the periodontal ligament and in the regenerating periodontium is not yet 
well defined. Growth factors may have a stimulating effect on several cell types (Matsuda 
et al., 1992). Several growth factors are considered to be the major local stimulators of 
bone formation (Canalis et al., 1988). Many growth factors such as bFGF, aFGF and IGF 
are bound within the extracellular matrix, and these together with degradation products of 
the matrix are released during inflammation (Bartold and Narayanan, 1998). 
 
2.6. Fibroblast Growth Factor 
 
Fibroblast growth factor (FGF), first isolated by Gospodarowiz in 1974, is found both in an 
acidic and a basic form. FGFs were first isolated from bovine brain extracts based on their 
mitogenic and angiogenic activities. Subsequent research established that FGFs form a 
family of structurally related polypeptide growth factors. They have diverse activities, and 
are produced at the same point during the development of each of the four histological 
tissue types (epithelia, muscle, connective and nervous tissues). Even though FGFs and 
their target cells are widely distributed through out the developing and the adult body, each 
FGF and FGF receptor show restricted, albeit overlapping, spatial and temporal expression 
pattern. The regulation of synthesis and activity of FGFs and their receptors is complex 
and occurs at all levels of processing, including activation of transcription, posttranslation 
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initiation (glycosylation, phosphorylation, and ribosylation), intracellular trafficking, 
secretion, bioavailability, and ligand-receptor interactions (Szebenyi and Fallon, 1998).   
 
2.6.1. Types of Fibroblast Growth Factor 
 
There have been at least 23 different FGFs of the FGF family so far described and one of 
the major themes of FGF biology has been the ongoing effort to discover how each factor 
delivers a biologically relevant signal in ways that are tissue–specific (Cool et al., 2002). 
FGFs belong to a family of structurally related polypeptide growth factors, designated by 
the acronym FGF and a number (FGF-n) and some of the members have other names. The 
nomenclatures of FGFs are, aFGF (FGF-1), bFGF (FGF-2), int-2 (FGF-3), kaposi sarcoma 
FGF (K-FGF & FGF-4), FGF-5, FGF-6, keratinocyte growth factor (KGF or FGF-7), 
androgen-induced growth factor (FGF-8) and glial growth factor (FGF-9), FGF10, FHF-3 
(FGF-11), FHF-1 (FGF-12), FHF-2  (FGF-13), FHF-4 (FGF-14), FGF-15, EGL-17, BNL 
(Emoto et al., 1997). They are multifunctional regulatory peptides and they have great 
impact on studies of tumorigenesis, cardiovascular disease, repair of tissue injury, 
neurobiology and embryonic development (Wahl et al., 1989). The members of this family 
have varying homology at the protein level but they have a similar broad mitogenic 
spectrum and they promote the proliferation of a variety of cells of mesodermal and 
neuroectodermal origin and also angiogenic (Basillico and Moscatelli, 1992). 
 
There are mainly two FGFs, aFGF and bFGF, which are dramatically distinct from other 
members of the family in the sense that they are widely distributed in tissues and are 
expressed by large number of cells. Therefore aFGF and bFGF have been the most 
intensely studied growth factors however the other members of this family may also 
support tissue repair (Basilico and Moscatelli, 1992). The bFGF secreted by macrophages, 
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osteoblasts, fibroblasts, endothelial cells and most cells of mesodermal origin (Graves et 
al., 1994). The bFGF has been shown to stimulate extracellular matrix metabolism, growth, 
and migration of mesodermally derived cells (Gospodarowicz, 1985). In fact it was 
reported that bFGF can be therapeutic in duodenal ulcer, chronic pressure sores, and 
infracted myocardium cases by its angiogenic action. Furthermore, in vivo studies have 
demonstrated that a topical application of exogenous bFGF also enhanced the healing 
process of bone fracture (Kawaguchi et al., 1994).  
 
2.6.2. Fibroblast Growth Factor Receptors 
 
FGF receptors are members of the receptor tyrosine kinase superfamily and these proteins 
contain an extracellular ligand binding domain, a single transmembrane domain, and an 
intracellular tyrosine kinase domain (Johnson and Williams, 1993). The FGF receptor 
extracellular region contains three immunoglobulin (Ig) - like domains, a heparin-binding 
domain, and a stretch of seven conserved acidic amino acids (Fig. 3) (Lee et al., 1989). 
There are 4 types of FGF receptors, FGFR-1, FGFR-2, FGFR-3 and FGFR-4 that have 
been cloned (Murakami et al., 1999). All these four receptors bind both aFGF and bFGF 
with high affinity (Partanen et al., 1992). Two classes of FGF binding sites have been 
characterized on cell surfaces. They are high affinity and low capacity receptors which are 
transmembrane glycoproteins containing an intrinsic tyrosine kinase activity (Jaye et al., 
1992). The others are low affinity and high capacity receptors that are cell surface 
proteoglycans containing heparan sulfate side chains. The high affinity receptors are the 
signal transducing receptors while low affinity receptors play a role in FGF storage and 
stabilization (Klagsbrun, 1990).  
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Takayama et al (1998) examined the kinetics of bFGF binding to receptors on human 
periodontal ligament cells. The binding was found to reach a maximum after 2.5 hours of 
incubation and then gradually decreased. It has also been found that the average number of 
FGFRs was 1x104 per cell. In addition, the binding of bFGF to PDL cells could be 
displaced by aFGF, as the two polypeptides are about 55% identical in amino acid 
sequence with genes of similar exon-intron structures. The RT-PCR based studies showed 
that human PDL cells express mRNA of FGFR-1 and FGFR-2 but not FGFR-3 and FGFR-
4. 
 
2.6.3. Basic Fibroblast Growth Factor (bFGF) 
  
The bFGF is the predominant and more potent form than the other members in the family. 
The bFGF is a member of family of heparin binding growth factors that has been 
implicated as an important mediator in wound healing (Thomas et al., 1997). This is a 
single-chain polypeptide found in macrophages and other mesodermally derived cells. The 
bFGF is a potent mitogen, angiogenic agent and chemoattractant for the cells involved in 
wound healing (Gospodarowicz et al., 1987). The bFGF has been implicated in diverse 
physiological actions like embryonic induction of mesoderm, angiogenesis, skeletal muscle 
regeneration and inhibition of myoblast differentiation, proliferation of chondrocytes and 
enhancement of extra cellular matrix formation (Ledoux et al., 1992).  
 
2.6.4. bFGF -Storage and Release 
 
 
The bFGF is a cell-associated protein that has been localized to the cytoplasm and 
extracellular matrix and it is activated in cell injury. It does not have a signal sequence and 
it is released secondary to cell damage and result in subsequent cytolysis and proteolysis 
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(Muthukrishnan et al., 1991).  At the cell surface, bFGF binds to high affinity tyrosine 
kinase receptors (FGFR1-4) as well as low affinity heparan sulfate proteoglycans (HSPG) 
(Jaye et al., 1992). Heparan sulfate proteoglycans (HSPGs) are found predominantly on the 
cell surface and in extracellular matrix. The HSPG stabilize bFGF and protect it from 
proteolytic degradadtion and enhances its efficacy. These HSPGs serve as a reservoir of 
bFGF that can be released by enzymes that degrade the bFGF-HSPG binding (Saskela and 
Rifkin, 1990).  The role of low affinity HSPG receptors present the bFGF ligand to the 
high affinity tyrosine kinase receptors and activate the high affinity receptors and trigger 
the biological responses (Schlessinger et al., 1995). The controlled release of bFGF might 
be important for maintenance of intact tissues, while acute injury might induce a burst 
release of bFGF following extracellular matrix degradadtion and tissue destruction 
(Dinbergs et al., 1996). The bFGF can be released from heparan sulfate binding sites on the 
cell surface and in the matrix or by proteinase degradation of the extracellular matrix 
(Klagsbrun and D’More, 1991). Studies have also shown that it can be released from 
cytosolic storage sites through plasma membrane disruptions (Thompson et al., 1991). The 
bFGF also take advantage of non-specific interactions with the heparan sulfate chains and 
experience a form of one dimentional diffusion along the heparan sulfate chains allowing 
for accelerated movement through the matrix. It has been shown that the bFGF-HSPG 
complex is approximately 1 minute (Nugent et al., 1992). Based on this, the rapid kinetics 
of bFGF could facilitate a dynamic storage and release system for bFGF that would not 
absolutely require matrix degradadtion to trigger release (Dowd et al., 1999).  
 
2.6.5. bFGF- Biological Activities 
 
The bFGF is a broad spectrum and pleiotropic mitogen for growth and differentiation 
affecting many cell types and tissues derived from endoderm, ectoderm and mesoderm 
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(Dow et al., 2000). Numerous investigators have shown that bFGF stimulates the 
proliferation of various endothelial cells like bovine aortic, human umbilical vein, and 
adrenal endothelial cells in vitro (Folkman and Klagsbrun, 1987). The bFGF stimulates 
wound healing and tissue repair by promoting angiogenesis, cell proliferation, and non-
collagenous protein synthesis. Its profound effect on bone growth and development is 
evident in several bone and cartilage genetic diseases related to mutations of FGF receptors 
(Kress et al., 2000). Participants in wound repair such as fibroblasts, vascular smooth 
muscle cells, and endothelial cells, proliferate upon exposure to bFGF in vitro 
(Gospodarowicz, 1985).  
 
2.6.6. Presence of bFGF in Normal Periodontal Tissues 
 
 
The cementum sequesters several growth factors including aFGF and bFGF, BMPs, TGF-β 
and an IGF-I –like molecule and growth factor receptors (MacNeil and Somerman, 1993, 
Cho et al., 1988). Cementoblasts of the cellular cementum appear to produce these proteins 
(Tenorio et al., 1993). In periodontium, bFGF is present in the extracellular matrix, as well 
as in the cementum and can function as a local factor at the site (Gao et al., 1996). 
Macrophages, smooth muscle cells, vascular endothelial cells and fibroblasts have all been 
shown by immunohistochemistry to contain bFGF (Klagsbrun and D’More, 1991, 
Thompson et al., 1991). Within the extracellular matrix of the alveolar bone, fibronectin, 
bone sialoprotein, osteopontin and several other cell adhesion molecules are stored, along 






2.6.7. Periodontal Healing and bFGF 
 
 
The bFGF modulates the cellular functions of a wide variety of cells of mesodermal, 
neuroectodermal and endodermal origin in vitro (Ledoux et al., 1992). Periodontal 
regeneration involves complex molecular and cellular mechanisms orchestrating multi-
factorial interactive functional events (Sae-Lim et al., in press). The bFGF has been shown 
to enhance human PDL and endothelial cell attachment and proliferation by providing a 
biochemical signal for PDL cells (Terranova et al., 1989). Also, bFGF is highly expressed 
in fibroblasts and endothelial cells derived from PDL, and are reduced in diseased tissues 
(Gao et al., 1996). The fact that bFGF is highly expressed in PDL and endothelial cells 
suggest that it plays a role in PDL-mediated mitogenesis and angiogenesis during the early 
wound healing process (Murakami et al., 1999).  
 
2.6.7.1. Dentine and bFGF 
 
Dentin bound bFGF positively influences the adhesion, migration and proliferation of 
human endothelial cells and human periodontal ligament cells (Terranova et al., 1989). 
Using dentin block proliferation assay system Tweden et al (1989) have demonstrated the 
capillary endothelial cell adherence, proliferation, and self-assembly into tubules on dentin 
can be obtained and is in part FGF dependent. In addition, it has been demonstrated that 
endothelial cells can be induced to migrate into a stromal collagen matrix and self-
assemble into capillary-like structures by exposure to gradients of fibroblast growth factor. 
Based on the histological evaluation of the periodontal wound, angiogenesis will occur in 
the soft tissue following invasion of the clot by mesenchymal cells. However, it is not 
generally recognized that neo-vascularization may play a significant role in the union of 
soft tissue to dentin. Tweden et al (1989) proved that FGF would support Human 
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Umbilical Vein Endothelial Cells (HUVEC) migration, proliferation and self-assembly on 
dentin surfaces. And it has been suggested that controlling the interaction at the interface 
(ie, dentin/connective tissue or bone/implant) by applying growth factors to induce 
angiogenesis will enable successful healing at an increased rate. 
 
2.6.7.2. Cementum and bFGF 
 
When compared to the other mineralized structures such as dentin and alveolar bone, the 
current understanding of the process which control and direct the cementum formation is 
limited. In primates, local exposure to bFGF has been shown to enhance healing and 
formation of new cementum in periodontal defects (Takayama et al., 2001). Sato et al 
(2004) demonstrated that bFGF accelerates healing of periodontal tissue, especially 
cementum and periodontal ligament, using an experimental model of root surface defects 
in beagle dogs. The above findings indicate that cementum may be capable of regulating 
the metabolism and turnover of surrounding tissues; especially it is actively participating in 
periodontal regeneration (Nakae et al., 1991). 
 
2.6.7.3. PDL and bFGF 
 
In vitro analysis of human PDL cells using RT-PCR revealed that bFGF enhances the 
proliferative responses of human PDL cells, which express FGFR-1 and FGFR-2. It has 
also been confirmed that bFGF enhanced the proliferative responses of PDL cells in a dose 
dependent manner. It has been demonstrated that mRNA expression was first detected in 
immature granulation tissue on 3rd day and upregulated for up to 7 days and decreased 
afterwards (Murakami et al., 1999). 
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Takayama et al (1997) examined the effects of bFGF on human periodontal ligament cells 
by culturing the cells. When focused on the biological effects, the bFGF could accelerate 
ideal periodontal regeneration without ankylosis and down growth of epithelium. It has 
been found that bFGF induced proliferation of PDL cells but inhibited the induction of 
alkaline phosphatase activity and also regulated the synthesis of type-1 collagen, which is 
one of the most common extracellular matrices in the periodontium, and it was more 
essential for calcified nodule formation. Their study showed similar effects in osteoblast 
cells. So, it has been suggested that the bFGF induces proliferation but inhibits 
cytodifferentiation of PDL cells into osteogenic cells.  
Takayama et al (1997) speculated that topical application of bFGF might increase the 
number of multipotent immature cells, which play crucial roles in periodontal regeneration 
during early phase of the wound healing process. It has been found that bFGF actively 
regulates the production of laminin by PDL cells, which is one of the most important 
biological substances to participate in angiogenesis.  
Gao et al (1996) demonstrated the distribution of bFGF in human periodontal ligament 
tissue of freshly extracted teeth. They examined and compared the distribution in healthy 
and diseased tissues. They found strong staining in the nuclei and cytoplasm of fibroblasts, 
extracellular matrix and endothelial cells in the blood vessel walls of healthy tissue. The 
density and distribution of the staining in younger patients affected by chronic periodontitis 
and chronic gingivitis were similar to healthy tissue but the inflammatory cells did not 
show any expression. Also the tissue from older patients showed weaker or absence of 
staining. There were large number of fibroblasts and endothelial cells in healthy tissue. But 
in necrotic tissue the population of fibroblasts was relatively small. This decrease in 
fibroblasts reflects not only damage but also diminished periodontal repair. They 
postulated that fibroblasts in diseased tissue retain a potential ability to influence 
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regeneration but the activity of these cells might be affected by microbial enzymes and 
they need to be stimulated by growth factors.  
2.6.7.4. Alveolar Bone and bFGF 
 
Murakami et al (1999) examined whether local application of bFGF in surgically created 3-
wall bone defects in alveolar bone may enhance periodontal regeneration using beagle 
dogs and they found that bFGF significantly enhanced periodontal regeneration when 
compared to the control sites. The bFGF increases the number of undifferentiated 
mesenchymal cells, which differentiate into osteoblasts and cementoblasts, resulting in an 
enhancement of the potential of desirable periodontal tissue regeneration at the late phase 
of the healing process. It reveals that the basic FGF has a mitogenic effect on multipotent 
immature cells. It has also been noticed that no instances of epithelial down growth, 
ankylosis or root resorption in bFGF sites. The bFGF application significantly promoted 
PDL formation with new cementum deposits and new bone formation in amounts greater 
than in the control lesions.  
 
From the literature review, it has been understood that bFGF is actively participating in the 
early periodontal wound healing. The bFGF has been reported as a most potent growth 
factor by inducing angiogenesis, chemotaxis, attachment and proliferation of fibroblasts, 
osteoblasts, endothelial cells and undifferentiated mesenchymal cells in periodontal 
ligament (Terranova et al., 1989). It has also been demonstrated as a potent stimulator of 
periodontal regeneration, new cementum and bone formation (Murakami et al., 1999). The 
immunohistochemical studies showed that FGFs and FGFRs are present in the normal and 
regenerating periodontal tissue. Upto the author’s knowledge, there was no known study 
about the early expression of bFGF during periodontal healing of avulsed and replanted 
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teeth. The results of this study might provide an insight into the understanding of bFGF 
expression under optimal and adverse conditions such as immediate and delayed 
replantation respectively.  
 
Other growth factors such as PDGF, IGF and VEGF, have been shown to be involved in 
periodontal regeneration (Cochran et al., 1999, Giannobile, 1996, Howell et al., 1996, 
Graves and Cochran, 1994). Our research group is currently looking at the expression of 
PDGF, IGF and VEGF in healing periodontal tissues at the similar time points in the 
immediate and delayed replanted teeth. The combined results of the study on these growth 
factors could facilitate the spatial and chronological understanding of periodontal healing 




1) To evaluate the difference in expression of basic fibroblast growth factor between 
the normal periodontal tissue of the non-experimental teeth and the healing 
periodontal tissue of  both the optimal (immediate) and delayed replanted teeth. 
2) To evaluate the difference in the bFGF expression between the immediate and 
delayed replanted teeth at the same time point. 
3) To examine the difference in the bFGF expression among different time points 
within the immediate replantation group. 
4) To examine the difference in the bFGF expression among different time points 
within the delayed replantation group. 















4. Materials and Methods 
 
4.1. Animal Experiment 
 
4.1.1. Animal Model 
 
 
The dog model has been chosen in many studies to investigate on various factors 
influencing periodontal healing after experimental tooth replantation due to the remarkable 
ability of the periodontal tissues to reattach under a variety of surgical conditions 
(Anderson et al., 1968). Trope et al (1997) found that dogs are as suitable as monkeys for 
tooth replantation studies involving replacement resorption. This was also validated by 
subsequent studies (Sae-Lim et al., 1998). The aim of this study was to examine the 
expression of bFGF during periodontal healing of immediate and delayed replanted teeth. 
It was felt that, choosing a dog model would facilitate meaningful comparisons to the 
histological outcomes from the previous tooth replantation studies (Sae- Lim et al., 1998, 
Trope et al., 1997). This immunohistochemical results could serve as a basis for better 
understanding at a molecular level. 
 
 
4.1.2. Preparation of Animals 
 
Approval was obtained from the Review Committee of the Animal Holding Unit, Tan 
Tock Seng Hospital, Singapore for the animal surgical experiment. The animal 
experimental procedures were done in accordance with the International Guiding 
Principles for Animal Research (Howard-Jones, 1985). Sixty caries free, periodontally 
healthy, matured teeth from six adult mongrel dogs, weighing average of 20 kg were used 
for this study. All experiments were performed under general anesthesia. The animals were 
initially sedated by intra-muscular injection of 20mg/kg body weight of Thiopental, 
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followed by administration of 2% halothane via intubation. The animals were given 
intravenous saline during the procedures. 
 
4.1.3. Preparation of Experimental Teeth  
 
 
Mature second lateral incisors, and first, second and third premolars were used for the 
experiment. Complete oral examination for mobility, crown fracture, and gingival 
inflammation was performed. X-rays were also taken before and after the operative 
procedures.  
 
4.1.3.1. Root Canal Treatment 
 
Earlier studies have shown that optimal endodontic treatment under aseptic conditions 
could eliminate inflammatory root resorption arising from potential infection of a necrotic 
pulp in a replanted tooth (Sae-Lim et al., 1998, Trope et al., 1992, Hammarstrom et al., 
1986). Intraoral root canal treatment was performed prior to extraction simulating avulsion 
injury so as to avoid further injuries to root surface stemming from extra-oral handling, 
including possible chemical damage from the root canal irrigants and sealers, to the 
remaining periodontal ligament cells (Andreasen, 1981). This replacement resorption 
protocol would facilitate exclusive investigations into the sequelae resulting from damage 
and/or bacterial contamination to periodontal tissues on or adjacent to the root surface 
without superimposition of pulpal component (Sae-Lim et al., 1998). The two-rooted 
second and third premolars were then hemi-sected and each root was considered as a 
separate unit (Sae-Lim et al., 1998). After root canal treatment, the teeth were extracted as 
atraumatically as possible.  
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It has been demonstrated that the removal of the coagulum before replantation has no 
influence on periodontal healing (Andreasen, 1980). As in the earlier studies by our group, 
gentle saline-irrigation on the roots and tooth sockets without removal of coagulum was 
carried out to remove any contamination (Wong and Sae-Lim, 2002). The blood clot might 
serve as a functional matrix with platelets releasing growth factors possibly aiding in the 
process of periodontal healing. Other studies have shown that splinting did not improve 
periodontal healing after replantation while functional stimuli might prevent or eliminate 
replacement resorption in replanted teeth (Andreasen, 1975). In our study, sutures were 
done only for those roots merely for stabilization when indicated.  
 
4.1.4. Grouping of Samples 
 
 
The experimental teeth were randomly distributed into 2 treatment groups: 
Immediate replantation group: After extraction, the sockets and roots were rinsed gently 
with 5 ml of sterile saline and the teeth were gently replanted into the sockets immediately. 
 
Delayed replantation group: After extraction, the roots were bench-dried for 60 minutes. 
After 60 minutes the sockets and teeth were then rinsed gently with 5 ml sterile saline and 
then the roots were gently replanted into the sockets. Splinting was done only when 
necessary with resorbable sling sutures.  
 
It has been demonstrated that a monolayer of periodontal cells on root surfaces was able to 
multiply if immediate replantation was carried out, while severe cell damage occurs after 
the critical period of 60 minutes extra-oral dry time; and after 120 minutes there were no 
more viable periodontal cells on human replanted root surfaces (Soder et al., 1976). This 
basis provided framework for the formulation of protocol in this and the earlier 
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replantation studies (Lam and Sae-Lim, 2004). The immediate replantation group 
represents teeth that would ultimately lead to optimal clinical healing while the delayed 
replantation group implicates clinical problems where compromised periodontal healing is 
an issue due to complication of replacement resorption which, eventually would risk in 
tooth loss (Andreasen, 1981). 
 
4.1.5. Post-operative Management of Animals 
 
 
 Post-operatively, the dogs were fed with normal diet of wet dog chow (Science Diet, 
Hill’s Pet Nutrition, Inc, Topeka, Kansas) twice a day.  Post-operatively, 2 mg Amoxicillin 
(Betamox LA, Norbrook Lab Ltd.) and Buprenophine (Temgesic, Schering Plough) 0.03 
mg/kg body weight was given. The dogs were monitored closely everyday and found that 
they tolerated the surgery well and behaved normally. The observational periods were ½, 2, 
3 and 4 days. A group of non-experimental teeth were included for baseline observations. 
 
4.1.6. Specimen Preparation 
 
 
At the end of the observation periods, the animals were deeply anaesthetized with 
halothane. Transcardiac perfusion with 4% Para-formaldehyde and Ringer’s Solution was 
done by exposing left and common carotid arteries.  After sacrificing, the jaws containing 
the replanted teeth and the surrounding tissues were resected, placed immediately in 10% 
formaldehyde and postfixed for 8 weeks at 4°C.  The specimens were then decalcified 
using PH 7, 12% ethylene diamine tetra-acetic acid (EDTA). The EDTA was changed 





4.2. Laboratory Procedures 
 
4.2.1. Immunohistochemical Procedures 
 
 
The decalcified specimens were processed in the automatic tissue processor (Shandon 
Citadel 2000, Thermo Electron Corp) and then embedded in paraffin wax. The largest 
proportion of samples used in immunostaining was embedded in paraffin because it 
provides excellent morphological details and resolution. The tooth specimens in paraffin 
blocks were cut cross-sectionally in serial step-sections of 5µm thickness at 100 µm 
intervals, with a rotary microtome (Reichert HistoStat, Leica, Germany).  Two sections 
were picked up at each sectioning level one for bFGF staining and other for negative 
control. The immunohistochemical staining was performed using ABC technique. After 
dewaxing and rehydration steps, the specimens were pretreated with hyaluronidase (Roche 
Diagnostics, GmbH, Mannhein, Germany). The results could be affected by the length and 
type of fixation that may mask antigens. So, it was essential to perform antigen unmasking 
to retrieve the antigen receptive to the antibodies. While many options of antigen masking 
are available, trials were needed to select the relevant one for the specific tissue. The 
specimens in this study contained both soft and hard tissues; we used enzymatic antigen 
retrieval method, as heat method may detach the specimen from the slide. Followed by 
that, the specimens were treated with 3% hydrogen peroxide (H2O2) (ICM Pte Ltd, 
Singapore) to quench the peroxidase activity. Then the specimens were incubated 
overnight with the goat blocking serum at room temperature. The specimens were then 
treated with the rabbit polyclonal anti-human basic fibroblast growth factor primary 
antibody (FT 4210-15, US Biologicals) at the concentration of 1:500 ul of 10% PBS at 4 
degree celsius overnight. The polyclonal antibody is the best choice for the paraffin 
embedded specimens. However polyclonal antibodies lack specificity, it is highly sensitive 
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and more likely to identify multiple isoforms of the target protein (Mighell et al., 1998). 
Then rabbit secondary antibody (1drop) in 10ml of goat serum buffer solution (ABC Elite 
kit, Vector Laboratories, Inc. Burlingam CA) was applied on the specimens and incubated 
for 1 hour at room temperature. The “ABC” complex is applied on the specimens and 
incubated for 30 minutes at room temperature; the specimens were then treated with DAB 
solution for 10 minutes. The specimens were then washed with distilled water and then 
counterstained with Gill 3 modified hematoxylin (Merck KGaA, Darmstadt, Germany) for 
10 minutes, and then washed in distilled water. The slides were mounted with XAM (BDH 
Laboratory Supplies, Poole, England) and prepared for the evaluation. 
 
4.2.2. Immunohistomorphometric Analysis 
 
The evaluation was done under light microscope (Nikon Optiphot II, Japan) in accordance 
to the method modified from the morphometric analysis developed by Andreasen, (1987). 
The presence of basic fibroblast growth factor was evaluated double-blindly by two 
different examiners. The localization of bFGF was assessed based on the number of 
positively stained cells and degree of intensity of the staining in the tissue. The sections 
were viewed at magnification 4X and projected on a screen. A grid that contains 4 
intersecting lines, which were superimposed at the center of the root canal (Andersson et 
al., 1987), was placed on the screen and adjusted in a way that they would intersect the root 
surface at 8 points. This method of 8 point evaluation also produces results very close to 
the true values with the systematic error of 2% which is not much different from the 
method evaluating the whole circumference. The latter deviates from the true mean by 
1.1% (Andreasen, 1987). The region at each point where the lines intersected with the root 
surface were magnified to 40X and cell counting was done in that area. This allows 
registration of results on the representative areas of the convex buccal and palatal surfaces 
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as well as the concave proximal surfaces of the root. The total number of cells and the 
number of positively stained cells were computed as mean percentage of positive cell count 
for further analysis. Intensity grade was also recorded in a range of scores from 0 to 3. 
0- No staining 
1- Mild staining 
2- Moderate staining 
3- Strong staining 
 
4.2.3. Statistical Analysis 
 
The statistical analysis results are listed in Tables 1-10. Using Wilcoxon Signed Rank test, 
the inter-examiners variability was examined (Table 1). Comparisons of the non-
experimental group and both immediate and delayed replantation groups were done using 
Kruskal Wallis test and P value was set at 0.05 (Table 2-7). Further pairwise comparisons 
were done using Mann Whitney U test and the significant value was set at 0.01 to adjust 
for Type 1 error (Table 2-7). The statistical comparisons of immediate and delayed 
replantation group at each time point were done using Mann Whitney U test and the P 
value was set at 0.05 (Table 8). The statistical comparisons of cementum, PDL and bone  at 
each time point in both immediate and delayed replantation groups were done using 
Kruskal Wallis test and the P value was set at 0.05 (Table 9,10). Further analysis with 
Mann Whitney U test was done for the time groups with significant differences and the P 





Five out of six dogs tolerated the operative procedures well and they behaved normally 
with normal food intake. However, one dog was euthanized in view of manifestation of 
post operative debilitation. In addition, some root samples were lost due to the known 
difficulty in extraction relating to dense alveolar bone that resulted in subgingival fracture 
(Trope, 1997). This affected the sample size, which was initially designed to be 10 per 
group. The final sample size was 64 sample roots with 29 in the immediate-replantation 
experimental group and 29 in the delayed-replantation experimental group as well as 6 in 
the non-experimental baseline group. 
 
The inter-examiners variability was compared using Wilcoxon Signed Rank test (P< 0.05) 
to find any statistical significance. There was no significant difference between the results 
of two evaluators in both cell count and intensity score of cementum, PDL and bone (Table 
1).  
 
In cementum, about 75% of cells stained and the mean intensity score of the extracellular 
matrix was 0.86+0.16 (Table 2, 5) (Fig 6, 8, 10). The expression of bFGF appears as brown 
precipitates, the intensity of which being proportional to the quantity of bFGF in that 
particular area (Gao et al., 1996). The positive staining indicating the bFGF expression in 
the precemental and cemental matrices was observed (Fig 14). The granular layer of 
Tomes, located between the dentine and cementum was stained positive in all the 
specimens. The dentine matrix and dentinal tubules were also stained positive for bFGF. 
The extra-cellular matrix staining was darker than the intracellular part (Fig 9, 11). There 
were no significant differences between non-experimental group and immediate 
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replantation group and also between non-experimental group and delayed replantation 
group in the mean percentage of positive cell count (Table 2, 5).  
 
On the other hand, the mean intensity score of extracellular matrix was significantly higher 
in 2 days (P= 0.01) and 3 days (P= 0.01) immediate replantation groups compared to the 
non-experimental group (Table 2, Chart 2). And also in ½ day (P=0.01), 2 days (P=0.01) 
and 3days (P=0.00) delayed replantation groups the mean intensity score of extracellular 
matrix was higher when compared to the non-experimental group (Table 5, Chart 2). As a 
general pattern, there was strong staining in precementum matrix when compared to the 
cementum matrix was observed (Fig 14).  
 
 There was no significant difference between the immediate and delayed replantation group 
in cementum (Table 8).  
 
In PDL, 87% of cells stained in the non-experimental group and the mean intensity of the 
extracellular matrix was 1.12+0.25 (Table 3, 6, Charts 1, 2). The PDL extracellular matrix, 
blood vessels, endothelial cells and epithelial cell rests of Malassez were also stained 
positive for bFGF (Fig 6, 8, 10). The epithelial rests of Malasez were located usually in the 
close proximity to the cementum in the PDL (Fig 14).  
 
 There were no significant differences between non-experimental group and immediate 
replantation group in both the mean percentage of positive cell count and the extracellular 
matrix intensity (Table 3, Chart 1).  
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There were also no significant differences between the non-experimental group and 
delayed replantation group in both the mean percentage of positive cell count and the 
extracellular matrix intensity (Table 6, Chart 1).  
 
In PDL, statistically significant higher percentage of cell count (P=0.02) was observed in 
the immediate replantation group when compared to the delayed replantation group at ½ 
day time point (Table 8, Chart 1). 
 
In bone, both the osteoblasts and osteocytes were stained positive for bFGF (Fig 7, 9, 11). 
The osteoblasts at the periphery of bone nearer to the PDL were stained stronger than 
osteocytes found further away (Fig 11). The blood vessels in bone and the contents were 
stained positive. Strong staining was observed around the blood vessels (Fig 12). In the 
non-experimental group about 75% of cells stained positive for bFGF and the mean 
intensity score of the extracellular matrix was 1.08+0.16 (Table 4, 7).  
 
There was a significant difference between the non-experimental group and immediate 
replantation group in the percentage of cell count (P= 0.05) but there was no significant 
difference in the mean intensity of extracellular matrix (Table 4). Within the immediate 
replantation group, there was significantly higher percentage cell count (P= 0.02) observed 
in 4 days time group when compared to the ½ day time group (Table 4).  
 
There were no significant differences between the non-experimental group and the delayed 
replantation group in both the mean percentage of positive cell count and extracellular 
matrix intensity (Table 7).  
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There was no significant difference between immediate and delayed replantation groups in 
both percentage of cell count and mean intensity score in bone (Table 8).  
 
On comparing the different structures, at the 1/2, 2, 3 and 4 days immediate replantation 
groups and at ½ and 3 days delayed replantation group, there were significant differences 
between the three structures (Table 9). Further analysis with Mann-Whitney test showed 
that the cell count of cementum was statistically lower than PDL (P=0.01) in the ½ day 
immediate replantation group (Table 9, Chart 1). The cementum cell count was statistically 
higher than bone in ½ day immediate (P= 0.01), 2 days immediate (P=0.01), 3 days 
immediate (P=0.01) and ½ day delayed (P=0.00) replantation groups. And the PDL had 
significantly more cells stained positive than bone in ½ immediate (P=0.00), 2 days 
immediate (P=0.01), 3 days immediate (P=0.00) and ½ day delayed (P=0.01) replantation 
groups. No statistical significant difference was noted in the mean intensity score of the 
extracellular matrix of cementum, PDL and bone at any of the time points in both the 








6.1.1. Non-Experimental Group 
 
The non-experimental group served as a baseline to examine bFGF expression under 
physiological condition. Studies have shown that cementoblasts lining the primary 
cementum were indistinguishable from the PDL fibroblasts (Tenorio et al., 1993) close to 
the area of new cementum (Somerman et al., 1988) and that the PDL fibroblasts might be 
able to differentiate into cementoblasts and form the cementum (Okamoto et al., 1996). 
Though there is no direct evidence, it is speculated that bFGF is stored and expressed in 
cementoblasts, similar to bFGF expression in both osteoblasts and osteocytes (Hu et al., 
2003). The low affinity cell membrane heparan sulfate proteoglycans (HSPGs) has been 
shown to act as reservoirs for the binding of bFGF to their cell surface high affinity 
FGFRs, which inturn activate the high affinity receptors and trigger biological activities 
(Schlessinger et al., 1988). In addition, Bartold et al (1990) reported that HSPGs are 
present in the pericellular environment within the housing lacunae of cementoblasts. It is 
likely that cementoblasts become trapped in the cemental matrix with declining secretory 
activity while maturing into cementocytes (Tencate, 2003). Hence in the cementum, about 
75% of cells, majority cementocytes, stained positive for bFGF (Table 2, 5, Chart 1) with 
mild to moderate intensity most probably due to the slow turnover rate (MacNeil and 
Somerman, 1993).  
 
In the non-experimental group, the cementum matrix showed mild to moderate staining 
intensity for bFGF (Table 2, 5, Chart 2). Though there is no past evidence to support that 
the bFGF is present in cementum matrix, it has been reported that HSPG is present in 
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cementum matrix (Nanci and Somerman, 2003, Saygin et al., 2000). It is likely that bFGF 
released by the cementoblasts on the root surface, might have bound to the HSPG in 
cementum matrix and translocated to the inner surface of the cementum matrix by the 
above mentioned unknown signaling pathway mechanism. Whether this in turn signals the 
cemntocytes to release bFGF and bond to HSPG in extracellular matrix is unknown. This 
might have caused the positive staining in the non-experimental group.    
 
The precementum area appeared to stain darker (Fig 14) possibly due to increased cellular 
activities of cementoblasts compared to the cementocytes within the cementum proper 
(Berkovitz et al., 2002). The Cementum-Dentine Junction (CDJ) was darkly stained (Fig 
14). In rat molars, the origin of CDJ is unclear whether it was derived from the epithelial 
root sheath or from the cementoblasts. In humans it has been suggested that the CDJ 
contains enamel matrix protein and it is a product of epithelial root sheath (Berkovitz et al., 
2002). It has also been suggested that CDJ is not a clear delineation between structures and 
that extracellular matrix fibrils in dentine and cementum intermingle (Nanci and 
Somerman, 2003) and it is also appear to serve as an “intermediate layer” where 
periodontal fibers are attached to the dentine (Berkovitz et al., 2002). The clinical 
significance of this interface relates to regeneration of the periodontium following 
periodontal surgery. Although a layer of cementum may regenerate, histological 
examination showed a space between regenerated cementum and surface dentine indicating 
an absence of true union. (Berkovitz et al., 2002).  
 
Granular layer of Tomes was also strongly stained positive for bFGF (Fig 14) at the 
periphery of the root dentine by the presence of a dark granular zone. The dentinal tubules 
in this area branch more profusely and loop back on themselves which creates air spaces in 
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ground section (Berkovitz et al., 2002). It can be speculated that the bFGF could have been 
incorporated into the CDJ and the granular layer of Tomes during cementogenesis.   
 
The dentine matrix, dentinal tubules were stained positive for bFGF which is similar to the 
finding by (Roberts-Clark and Smith, 2000) in which bFGF was found within human 
dentine matrix. Smith et al (1998) showed that odontoblasts can express various growth 
factors, and little is known of their secretion into the dentine matrix. In view of the 
polarized nature, those growth factors are secreted by odontoblasts are stored in the dentine 
matrix. However, no studies have shown the mechanism by which the growth factors are 
released in to the extracellular dentine matrix.  
 
6.1.2. Non-Experimental Vs Immediate Replantation Group  
 
 
There was statistically higher mean intensity of extracellular matrix in the 2 days (P=0.01) 
and 3 days (P=0.01) immediate replantation groups compared to the non-experimental 
group (Table 2, Chart 2). McNeil et al (1999) reported that at the sites of traumatic injury 
the injured cells release bFGF. Studies have shown that bFGF released from cellular 
storage sites during injury stimulate growth and repair (Klagsbrun and D’Amore, 1991). In 
cementum, upon injury, the cementoblasts on the root surface release bFGF that would 
bind to the extracellular matrix HSPG (Klagsbrun, 1990). The transient association and 
dissociation kinetics of bFGF and heparan sulfate binding suggested that the average life of 
a bFGF-HSPG complex was approximately 1 minute (Nugent et al., 1992). This rapid 
binding could facilitate a dynamic storage and release system for bFGF that would not 
absolutely require matrix degradation to trigger release (Dowd et al., 1999). It is speculated 
that the extracellular matrix bound bFGF translocated to the inner surface of the cementum 
by an unknown signaling pathway mechanism. The bFGF has been reported to be a potent 
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mitogen (Graves et al., 1994) and it might induce the cellular activity of the cementocytes, 
which might account for the darker staining in the immediate replantation group, though no 
significant difference in the mean percentage of positive cell count (Table 2, Chart 1) 
compared to the non-experimental group. 
 
The proliferative stage starts on the 2nd day (Trowbridge, 1997), during which there was 
assumably increased disassociation of bFGF from cementoblasts on root surface possibly 
resulting in enhanced signaling and dynamic exchange of extracellular matrix bound bFGF 
assembly (Nugent et al., 1992). This might explain the increase in the extracellular matrix 
staining intensity in the 2 and 3 days immediate replantation groups. The cementum-
dentine junction (CDJ), granular layer of Tomes, dentine matrix and dentinal tubules were 
stained positive as in non-experimental group. 
 
6.1.3. Non-Experimental Group Vs Delayed Replantation Group 
 
There was no significant difference in the mean percentage of positive cell count between 
the non-experimental group and delayed replantation group except that the cells in delayed 
replantation group stained strongly (Table 5, Chart 1). As explained earlier in the 
immediate replantation group, in delayed replantation group the bFGF released by the root 
surface necrotic cementoblasts might have translocated into the inner cementum matrix by 
an unknown signaling pathway mechanism. Extracellular bFGF can be endocytosed and 
transported within cells (Munoz et al., 1997). And this upregulated bFGF might have 
caused the strong staining in cementocytes in the delayed replantation group.   
 
There were significantly higher mean intensity score in ½ day (P=0.01), 2 days (P=0.01) 
and 3 days (P=0.00) of the delayed replantation groups when compared to the non-
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experimental group (Table 5, Chart 2). For the ½ day delayed replantation group, it is 
speculated that due to the necrosis of the cells on the root suface, the bFGF is released and 
translocated to the inner surface of the cementum. For the 2nd and 3rd day, the mechanism 
is similar to the 2nd and 3rd day of immediate replantation group. During the proliferative 
stage, the assembly and dissociation of bFGF from cementoblasts on root surface possibly 
resulting in enhanced signaling and dynamic exchange of extracellular matrix bound bFGF 
assembly (Nugent et al., 1992). This might account for the increased intensity of 
extracellular matrix on the 2nd and 3rd day. 
 
6.1.4. Immediate Vs Delayed Replantation Group 
 
There was no significant difference both in the percentage of positive cell count and 
extracellular matrix intensity between immediate and delayed replantation groups in 
cementum at all the time points (Table 8). Even though tissue damage and inflammation 
occurs in both the groups, there might be more necrotic cells and tissue present in the 
delayed replanted roots (Soder, 1976). This increased necrosis would result in prolonged 
inflammation. In addition, the inflammatory process is still ongoing on the 4th day in both 
the groups; it might not be possible to see any differences within this short observation 





6.2.1. Non-Experimental Group 
 
 
In the periodontal ligament, 87% of the cells were stained for the bFGF but with mild 
intensity (1.12±0.25) (Table 3, 6, Chart 1). Biochemical data from in vitro studies indicate 
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that the periodontal ligament contains a heterogeneous cell population such as fibroblasts, 
cementoblasts, osteoblasts and endothelial cells (Roberts et al., 1987) which the bFGF has 
broad specificity with except in cementoblasts (Hurley et al., 1994). Immnulocalisation of 
bFGF has been shown in nuclei and cytoplasm of PDL fibroblasts (Gao et al., 1991). 
Intracellular localized bFGF could induce stimulation and proliferation of fibroblasts 
without being secreted and it is based on cell surface receptor independent mechanisms 
(Bikfalvi et al., 1995). Murakami et al (1999) showed the expression of mRNA of FGFR-1 
and FGFR-2 in human periodontal cells. The bFGF has been shown as a chemotactic and 
mitogenic factor for undifferentiated progenitor PDL cells (Terranova et al., 1989). The 
PDL turnover rate is very high compared to any other tissues (Hughes, 1995). It is assumed 
that the undifferentiated progenitor cells were present during normal physiology, allowing 
continuous remodeling and homeostasis. There was an influx of progenitor cells while the 
matured cells undergo apoptosis (McCulloch, 1995).  
 
In line with Gao et al (1996) immunopositive staining of bFGF was observed in the PDL 
extracellular matrix (Tables 3, 6, Chart 2). The presence of bFGF in extracellular matrix 
might indicate that bFGF released from fibroblasts and endothelial cells is stored in 
extracellular matrix where it may have a role in stimulation of fibroblasts (Gao et al., 
1996).  
 
In non-experimental group, the epithelial cell rests of Malassez in PDL were stained 
positive (Fig 14). It has been suggested that epithelial cell rests of Malassez are actively 
participating in cementogenesis (Berkovitz et al., 2002). The presence of bFGF shows the 
possibility of its mitogenic role in cementogenesis.  
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The blood vessels and the endothelial cells lining the blood vessels were stained positive 
(Fig 14) which is similar to the observation by Gao et al (1996). The bFGF has been shown 
to promote endothelial cell proliferation and differentiation (Kanda et al., 1996).  
 
6.2.2. Non-Experimental Vs Immediate Replantation Group 
 
There was no significant difference in the mean percentage of positive cell count between 
the non-experimental group and immediate replantation group (Table 3, Chart 1). However 
the cells in the immediate replantation group stained darkely compared to the non-
experimental group. During extraction, attachment damage occurs and the tooth is 
separated from the socket. The tearing of the periodontal ligament leaves viable 
periodontal ligament cells on most of the root surface (Trope, 2002). Under optimal 
condition as in the immediate replantation group, these viable cells proliferate. The bFGF 
has been shown to enhance not just periodontal cell proliferation but also proliferation and 
attachment of endothelial cells (Terranova et al., 1989) involving in angiogenesis 
(Folkman, 1982). It is speculated that the angiogenesis induced by bFGF allows high 
turnover rate of PDL.  
 
There was also no significant difference in the extracellular matrix intensity between the 
non-experimental group and immediate replantation group. During injury, the platelets 
release heparin degrading enzymes which might degrade bFGF from the extracellular 
matrix HSPG binding and induce the angiogenesis (Oosta et al., 1982). The initiation of 
angiogenesis might have stimulated high turn over rate of PDL and maintained the balance 
between the assembly and dissociation of bFGF and this account for the insignificant 
difference between non-experimental group and immediate replantation group. 
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6.2.3. Non-Experimental Vs Delayed Replantation Group 
 
There was no significant difference between the non-experimental group and delayed 
replantation group (Table 6, Chart 1). However, the PDL cells in the delayed replantation 
group stained darker than the non-experimental group. After avulsion, the teeth which were 
subjected to excessive drying before replantation, the necrotic cells will elicit severe 
inflammatory response (Trope, 2002) and release bFGF. The bFGF is stored in the 
basement membrane of cells (Klagsbrun, 1990) and during injury heparanases and 
proteinases are released from macrophages and thus in turn degrade HSPG-bFGF binding 
and release bFGF (Presta et al., 1989). The bFGF acts as a potent chemotactic, mitogenic 
agent for PDL cells (Howell et al., 1996), stimulating the influx and proliferation of 
paravascular osteoprogenitor cells. The increased cellular activity in the PDL might 
account for the intense staining of the cells in the delayed replantation group. 
 
There was no significant difference in the extracellular matrix intensity (Table 6, Chart 2) 
observed in the delayed replantation group compared to the non-experimental group. The 
interaction of bFGF with heparin and heparan sulfate is observed in the extracellular matrix 
of chondrosarcoma (Shing et al., 1984). Similar to the immediate replantation group, the 
bFGF bound within the extracellular matrix, together with degradation products of the 
matrix, are released during inflammation (Bartold and Narayanan, 1998). But at this early 
stage of wound healing, the effect of necrotic cells in PDL might not be sufficient to show 





6.2.4. Immediate Vs Delayed Replantation Group 
 
In PDL, higher percentage of positive cell count observed in the immediate replantation 
group when compared to the delayed replantation group at ½ day time point (P=0.02) 
(Table 8, Chart 1). It has been shown that at the site of injury the bFGF is relased from 
cells through plasma membrane disruptions (McNeil et al., 1989). Periodontal fibroblasts 
(Andreasen, 1981), blood vessel endothelial cells present in PDL.  The fibroblasts and 
endothelial cells are known to release bFGF (Graves and Cochran, 1994). And also the 
macrophages in the wound release bFGF (Faktorovich et al., 1992). Under favourable 
condition as in immediate replantation group, the released bFGF might stimulate 
chemotaxis and proliferation of the PDL cells (Murakami et al., 1999) increases the 
cellular activities. The increased cellular activity might have upregulated the bFGF in the 
cells. In the delayed replantation group, the PDL is desiccated and the cells are mostly 
necrotized. The necrotizing cells appeared to lose its metabolic activity including 
upregulation of bFGF. The Subsequent 2nd and 3rd day, the influx of progenitor cells occurs 
more so in the immediate replantation group than the delayed replantation group (Melcher 
et al., 1986). However, the balance between the influx of progenitor cells and the 
upregulated cells in the immediate replantation group as well as the minimal progenitor 
cells influx and the necrotic cells in the delayed replantation group appeared to be 
maintained.  
 
6.3. Bone  
 
6.3.1. Non-Experimental Group 
 
Although 70.44% of the cells stained positive in non-experimental group, the intensity of 
the cells were mild (1.08±0.16) (Table 4, 7, Chart 1) the bFGF is stored in an inactive form 
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when there is no injury (Gibran et al., 1994). The bFGF was shown to be produced by 
osteoblasts, stored in bone matrix and induce bone formation (Mohan and Baylink, 1991). 
Studies have shown that bFGF is a strong mitogen for osteoblasts and also induces bone 
formation by stimulating proliferation and differentiation of mesenchymal osteoprogenitor 
cells (Hanada et al., 1997). In the current study it was observed that osteoblasts nearer to 
the PDL stained more intensely than the osteocytes located further away from the PDL. 
This is in line with the study reported by Hu et al (2003) that bFGF stained strongly in the 
osteoblasts lining the immature bone than the osteocytes present within the bone matrix. 
Studies showed that the bFGF was highly mitogenic for preosteoblasts and its proliferative 
effect on differentiated osteoblasts was limited (McCarthy et al., 1989). As explained in 
PDL, that during normal physiology, bone undergoes continuous remodeling and 
homeostasis, as influx of osteoprogenitor cells occurs and the matured cells undergo 
apoptosis. 
 
In the current study, the extracellular matrix of bone stained with mild to moderate 
intensity (Tables 4, 7, Chart 2). Bone matrix is known to contain a large number of growth 
factor include bFGF (Hauschka et al., 1986). It has been suggested that bFGF is released 
by human osteoblasts and subsequently deposited in the bone matrix (Brunner et al., 1991). 
Heparan sulfate proteoglycan is a major constituent of extracellular matrix to which the 
bFGF bound and stored as a biologically active component of extracellular matrix (Graves 
and Cochran, 1994) to be mobilized when needed in conditions such as wound healing 
(Steenfos, 1994).  
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In the bone, blood vessels and endothelial cells are stained positive for the bFGF (Fig 12). 
The bFGF is a cell-associated protein that has been localized to the cytoplasm of the 
endothelial cells and extra-cellular matrix (Muthukrishnan et al., 1991).  
 
6.3.2. Non-Experimental Vs Immediate Replantation Group 
 
There was no significant difference between the non-experimental group and the 
immediate replantation group. Among the different time groups, in the immediate 
replantation group, higher percentage of positive cell count was seen in 4 day time group 
compared to the 1/2 day time group in bone (P=0.01) (Table 4, Chart 1). It has been shown 
that bFGF has anabolic effects on new bone formation (Nagai et al., 1995, Nakamura et al., 
1995). Frenkel et al (1992) demonstrated that the bFGF stimulated proliferation of 
osteogenic cells and indirectly enhanced the matrix formation as a result of an increase in 
cell number. Hence, on the 4th day there would be more differentiated cells and that might 
have increased the number of positive cells.  
 
There was no significant difference between the non-experimental group and immediate 
replantation group in the extracellular matrix intensity (Table 4, Chart 1).  In the case of 
immediate replantation group, as PDL undergoes optimal healing process, it does not exert 
much effect on indirectly damaged bone.  
 
The blood vessels and the endothelial cells were stained positively in the immediate 





6.3.3. Non-Experimental Vs Delayed Replantation Group 
 
In bone there was no significant difference between the non-experimental group and 
delayed replantation group in the mean percentage of cell count (Table 7, Chart 1). The 
necrotic PDL cells might not exert significant effect on bone where there was high cell 
turnover rate in early phase of healing.  
 
There was no significant difference between the non-experimental group and delayed 
replantation group in the mean intensity of extracellular matrix (Table 7, Chart 2). In the 
delayed replantation group, as the bone undergoes indirect damage, the effect of necrotic 
cells in PDL might not sufficiently significant on the early phase of wound healing to 
induce any significant difference on bone. 
 
6.3.4. Immediate Vs Delayed Replantation Group 
 
There was no statistically significant difference between immediate and delayed 
replantation group (Table 8). In delayed group, the presence of necrotic cells was shown to 
prolong the inflammatory process compared to immediate replantation group (Soder, 1976) 
but the effect might not be significant to show the difference between the two groups in the 
early phase of healing.  
 
6.4. Cementum Vs Bone 
 
 
The percentage of positive cell count in cementum was statistically higher than bone in ½ 
day (P= 0.01), 2 days (P=0.01), 3 days (P=0.01) immediate replantation groups. And also 
in ½ day (P=0.00) delayed replantation group the percentage of positive cell count was 
higher than in bone. It has been suggested that cementum may be capable of regulating the 
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metabolism and turnover of surrounding tissues (Nakae et al., 1991). The fibers of 
periodontal ligament run into the organic matrix of the precementum (Nanci, 2003) and 
this allows the cementum to participate in the formation and regeneration of periodontal 
ligament (Nakae et al., 1991). Dowd et al (1999) proposed that the bFGF could diffuse 
along the heparan sulfate chains allowing for accelerated movement through the 
extracellular matrix. Initially, in the ½ day immediate replantation group, the bFGF might 
be translocated to the inner cementum matrix through the above mentioned signaling 
mechanism and activated the cementocytes. The activated cementocytes transferred from 
the quiescent state to the activated state (Nugent et al., 1992). This might induce the release 
and uptake of the bFGF and the intensity of cells and number of positive cells increased. 
Studies showed that the proliferation phase of wound healing associated with the growth 
oriented cytokines and factors, capable of initiating extracellular matrix deposition and 
cellular proliferation (Falanga et al., 2002). On the other hand, during 2nd and 3rd days, the 
bone maintains the normal homeostasis due to indirect injury. While the root surface 
cementoblasts send signal to cemental matrix resulting in dissociation and association of 
bFGF with cell membrane HSPG of cementocyte. This upregulation of bFGF might have 
increased the number of positive cells in cementum. 
 
In the ½ day delayed group, the necrotizing cells in PDL might release bFGF and the 
released bFGF might activate an unknown signaling pathway through cementum. This 
signal activates the cementocytes and increases their activity causing the stronger staining. 





6.5. PDL Vs Bone 
 
The PDL had significantly more percentage of immuno positive cells than bone in ½ day 
(P=0.00), 2 days (P=0.01), 3 days (P=0.00) immediate replantation groups. And also in ½ 
day (P=0.01) delayed replantation group the percentage of positive cell count in PDL was 
significantly higher than in bone (Table 9, Chart 1). During avulsion, the bulk of direct 
injury occurs in PDL (Trope, 1995). In the ½ day immediate replantation group, the injured 
and ruptured endothelial cells (Muthukrishnan et al., 1991), periodontal ligament 
fibroblasts and the macrophages (Graves and Cochran, 1994) release bFGF. Being 
mitogenic (Terranova et al., 1989) and angiogenic (Tweden et al., 1989), the released 
bFGF induce PDL cell proliferation. The cellular proliferation might have increased the 
cellular activity and the upregulation of bFGF in the periodontal ligament cells. This might 
have increased the number of positive cells. On the 2nd day proliferation starts and the cells 
begin to proliferate and differentiate. During the 2nd and 3rd day, the osteoprogenitor cells 
from the adjacent bone migrate into the periodontal wound and start to differentiate.  
Previous studies have shown that paravascular fibroblasts can give rise PDL fibroblasts 
after wounding of the PDL (Gould et al., 1980). McCulloch et al (1987) have reported that 
progenitor cells migrate into the periodontal ligament from endosteal spaces in the adjacent 
alveolar bone, which give rise to both osteoblasts and cementoblasts. Based on this, it can 
be speculated that the influx of the progenitor cells and active proliferation and 
differentiation of cells (Murakami et al., 1999) might have increased the percentage of 
positive cells in the 2 days and 3 days immediate replantation groups.  
 
 For the ½ day delayed group, the periodontal ligament undergoes severe inflammatory 
response because of the presence of necrotic tissue on the root surface (Trope, 2002). The 
necrotic cells in PDL might not significant enough to induce any effect on bone at this 
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early phase of wound healing and this allows bone to continue its normal remodeling 
process which causes the lower percentage of positive cells in bone compared to PDL.  
 
6.6. PDL Vs Cementum 
 
 
The percentage of positive cell count in cementum was statistically lower than in PDL in 
the ½ day (P=0.01) immediate replantation group (Table 9, Chart 1). In the case of 
immediate replantation group, the source of PDL fibroblasts from the viable cells left in 
socket (Andreasen, 1981). Under appropriate inductive stimuli, paravascular progenitor 
cells could differentiate into PDL fibroblastic phenotype (Sae-Lim et al., in press). The 
released bFGF from the injured cells and the endothelial cells might stimulate multipotent 
immature mesenchymal cells and induce differentiation (Takayama et al., 1997). Studies 
have shown that cells from both the adjacent periodontal ligament and alveolar bone 
potentially migrate into regenerating periodontal wounds (Iglhaut et al., 1988). As with 
time, there were no further changes in cementum and periodontal ligament cell count. The 
initial trauma that induced the inflammatory response in PDL, accounted for the higher 














Based on the knowledge gained in literature review, it could be hypothesized that the 
traumatized and healing periodontal tissue may express the bFGF after replantation. And 
the degree of expression might vary in different stages of periodontal healing and at 
different structures of the periodontium.  
The null hypotheses state that: 
7.1. There would be no significant difference in the bFGF expression between the non-
experimental teeth and the immediate replanted teeth. 
7.2. There would be no significant difference in the bFGF expression between the non-
experimental teeth and the delayed replanted teeth. 
7.3. There would be no significant difference in the bFGF expression between immediate 
and delayed replantation groups at the same time point. 
3.4. There would be no significant difference in the bFGF expression at different time 
points of periodontal healing within the immediate replantation group. 
7.5. There would be no significant difference in the bFGF expression at different time 
points within the delayed replantation group. 
7.6. There would be no significant difference in the bFGF expression among different 








Based on the results of the current study, the following conclusions could be made: 
 
8. 1. There was no statistical significant difference between the non-experimental teeth and 
both the immediate and delayed replantation groups in the mean percentage of positive cell 
count.  
 
8.2. There were no significant differences between the non-experimental teeth and both 
immediate and delayed replantation group in the extracellular matrix intensity of PDL and 
bone. On the other hand, in cementum, there were significant differences between the non-
experimental group and 2 days and 3 days immediate replantation groups. And also 
between non-experimental group and ½ day, 2 days and 3 days delayed replantation 
groups.  
 
8.3. There was no significant difference in the mean percentage of positive cells in both 
cementum and PDL in the temporal expression of bFGF at different observation timing 
within immediate and delayed replantation groups. But there was a significant difference 
between ½ day immediate and 4 days immediate replantation groups in bone.  
 
8.4. The null hypothesis states that there would be no significant difference between the 
immediate and delayed replantation group at the same time point is valid in cementum and 
bone. On the other hand in PDL, there was statistically higher percentage of positive cells 




8.5. There was significantly higher percentage of positive cells count in PDL than in 
cementum at ½ day immediate replantation group.  
 
8.6. The cementum cell count was significantly higher than bone cell count in ½ day, 2 
days and 3 days immediate replantation groups. And also the cementum cell count was 
higher in ½ day delayed replantation group. 
  
8.7. There PDL cell count was significantly higher than the bone cell count in ½ day, 2 
days and 3 days immediate replantation groups. And also higher percentage of cell count 






























9. Future Directions 
 
Even though, there were no conclusive results, from the current study, the presence of 
bFGF both in physiological and pathological conditions indicates that it is actively 
involved in periodontal healing of replanted teeth. These results might provide an insight to 
the therapeutic role of bFGF in the treatment of replanted teeth.   
 
Future study with longer observation period and immunolocalization of FGFR might 
provide more information about the exact location and biological functions of bFGF in 
periodontal healing. Identification of different genes using genomics, encoding proteins 
using proteomics may provide valuable information and subsequent functional therapeutic 
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bFGF Immunoperoxidase cell staining  
1. Fix tissue in formalin, embed in paraffin wax and prepare sections of 5 microns 
thickness according to standard procedures. 
2. Deparaffinise the sections using two changes of xylene for 5 minutes each. 
3.  Hydrate the sections using the following order:  
i Absolute alcohol I (5 minutes) 
ii Absolute alcohol II (5 minutes) 
iii. 95% alcohol I (3 minutes) 
v.  95% alcohol II (3 minutes) 
vi.  Deionised water I (5 minutes) 
vii. Deionised water II (5 minutes) 
 
Aspirate excess liquid from the slides with filter paper. 
4. Immerse the slides completely in phosphate buffered saline (PBS) and incubate for 
5 minutes. Repeat once. 
5. Perform antigen unmasking by incubating with 1 mg Hyaluronidase in 2 ml of PBS 
for 10 minutes at room temperature. 
6. Immerse the slides completely in phosphate buffered saline (PBS) and incubate for 
5 minutes. Repeat once. 
7. Immerse the slides in 3% H2O2 for 15 minutes to quench the endogenous 
peroxidase activity. 
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      8.  Immerse the slides completely in phosphate buffered saline (PBS) and incubate for 
5 minutes. Repeat once.  
      9.  Incubate specimens for 60 minutes in 1.5% blocking serum in PBS. The blocking 
serum should ideally be derived from the same species in which the secondary 
antibody is raised. In the current study, goat serum was used. After incubation the 
excess serum was removed from the specimens by carefully blotting the liquid with 
filter paper. 
      10. Incubate with the primary antibody (rabbit polyclonal IgG antibody to bFGF (FT 
4210-15, US Biologicals) at 1:500 dilution overnight at 4°C. 
     11.  Immerse the slides completely in phosphate buffered saline (PBS) and incubate for 
5 minutes. Repeat once. 
     12.  Incubate at room temperature for 60 minutes with the biotin conjugated secondary 
antibody (Vectastain@ ABC Kits, Rabbit IgG, PK-6101, Vector Laboratories Inc) 
at a dilution of 1 drop in 10 ml PBS. 
     13.  Immerse the slides completely in phosphate buffered saline (PBS) and incubate for 
5 minutes. Repeat once. 
     14.  Incubate sections at room temperature with the avidin-biotin enzyme reagent 
(Vectastain@ ABC Reagent, Vectastain@ ABC Kits, Rabbit IgG, PK-6101, Vector 
Laboratories) at a dilution of 1 drop of Solution “A” and 1 drop of Solution “B” in 
2.5ml of PBS for 30 minutes. 
     15.  Immerse the slides completely in phosphate buffered saline (PBS) and incubate for 
5 minutes. Repeat once. 
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     16.  Incubate sections at room temperature in peroxidase substrate solution 
(diaminobenzidine tetrahydrochloride, DAB substrate kit, SK-4100, Vector 
Laboratories) for 10 minutes. 
     17.  Counter stain by immersing in Haematoxylin for 10 minutes. Immerse in 3 changes 
of deionised water for 5 minutes each time. 
     18.  Dehydrate the sections using the following order 
i. 95% alcohol I (3 minutes) 
ii. Absolute alcohol I (5minutes) 
iii. Absolute alcohol II (5minutes) 
            iv. Xylene I (5minutes) 
vi. Xylene II (5minutes) 
Wipe off excess xylene carefully. 
     19.  Immediately put a drop of Permount or any mounting media and place a coverslip 
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Histological Structure of Periodontium  
 
Light microscopic image shows eosin and haematoxylin staining of the periodontal 
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Figure 3  
 
Structure of the Fibroblast Growth Factor Receptor 
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Light microscopic image of immunohistochemical staining of negative control sample 
counterstained with haematoxylin (bFGF primary antibody omitted) shows no staining in 
cementum and PDL (400X magnification) 
 








Yellow Arrow - Cementocyte 
 
White Arrow – Periodontal Ligament Fibroblast 
 CementumDentine 




Light microscopic image of immunohistochemical staining of negative control sample 
counterstained with haematoxylin (bFGF primary antibody omitted) shows no staining in 
bone and PDL (400X magnification) 
 
















Light microscopic image of ½ day- immediate time group sample undergone 
immunohistochemical staining with haematoxylin counterstain shows mild expression of 































 Positively stained PDL Mildly stained cementocyte
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Light microscopic image of ½ day- delayed group sample undergone 
immunohistochemical staining with haematoxylin counterstain shows mild expression of 
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Light microscopic image of 2 days-delayed group sample undergone immunohistochemical 
staining with haematoxylin counterstain shows moderate expression of bFGF in cementum 
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Light microscopic image of 2 days-immediate group sample undergone 
immunohistochemical staining with haematoxylin counterstain shows moderate expression 











fibroblast in PDL Positively stained bone
matrix  
Positively stained 
Osteoblast in bone114 
Figure 10 
 
Light microscopic image of 3days-delayed group sample undergone immunohistochemical 
staining with haematoxylin counterstain shows strong expression of bFGF in cementum 
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Light microscopic image of 3 days-delayed group sample undergone immunohistochemical 
staining with haematoxylin counterstain shows strong expression of bFGF in bone and 









































Light microscopic image of 4 days-immediate group sample undergone 
immunohistochemical staining with haematoxylin counterstain shows bFGF expression in 
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Light microscopic image of non-experimental sample stained for negative control (omitted 
bFGF antibody) shows no staining in the blood vessels and cell rests of Malassez in PDL 








Light microscopic image of non-experimental sample stained using immunohistochemical 
technique with haematoxylin counterstain shows staining of the blood vessels and cell rests 
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 Table 1: Comparison of inter-examiners variability using Wilcoxon Signed Ranks Test (P<0.05) 
CCC      CIS PCC PIS BCC BIS
0.24      0.96 0.74 0.23 0.59 0.35
 
CCC: cementum cell count  PCC: PDL cell count  BCC: bone cell count 
 




























NEC (6) 67.20 100 75.96+13.82     
½ Imm (7) 69.47 95.42 82.44+10.34 NEC vs Imm gps 0.17   
2 Imm (5) 77.93 94.09 87.33+6.11     




4 Imm (6) 78.99 95.83 90.01+.6.90     
NEC(6) 0.67 1.05 0.86±0.16   Ne vs ½ Imm 0.02 
½ Imm (7) 0.96 1.83 1.15±0.31 NEC vs Imm gps        *0.04 Ne vs 2 Imm        *0.01 
2 Imm (5) 1.00 2.27 1.34±0.53   Ne vs 3 Imm       *0.01 
3 Imm (11) 0.98 1.54 1.23±0.21 Imm gps 0.70 Ne vs 4 Imm 0.03 
4 Imm (6) 1.00 2.20 1.47±0.57   ½ vs 2 Imm 0.20 
      ½ vs 3 Imm  0.54 
      ½ vs 4 Imm  0.43 
      2 vs 3 Imm  0.95 













CCC: cementum cell count   Imm: immediate replantation 
CIS: cementum intensity score  NEC: non-experimental cementum 
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NEP (6) 61.67 100 87.28+18.24   
½ Imm (7) 91.66 100 97.67+3.71 NEP vs Imm gps 0.82 
2 Imm (5) 88.32 100 96.33+5.33   




4 Imm (6) 89.10 100 95.26+5.59   
NEP(6)      0.92 1.60 1.12±0.25
½ Imm (7) 1.00 2.00 1.27±0.36 NEP vs Imm gps 0.40 
2 Imm (5) 1.06 1.66 1.27±0.24   












PCC: PDL cell count   Imm: immediate replantation 




















NEB (6) 62.63 92.26 73.80±11.17   NE vs ½ Imm 0.18 
½ Imm (7) 51.87 74.96 63.88±7.95   NE vs 2 Imm 0.33 
2 Imm (5) 49.34 71.27 63.64±8.80 NEB vs Imm gps *0.05 NE vs 3 Imm 0.73 
3 Imm (11) 58.44 97.40 76.13±11.40   NE vs 4 Imm 0.39 
4 Imm (6) 66.34 95.58 78.07±9.86   ½ Imm vs 2 Imm 0.88 
      ½ Imm vs 3 Imm 0.04 
      ½ Imm vs 4 Imm        *0.01 
    Imm gps *0.02 2 Imm vs 3 Imm 0.05 






      3 Imm vs 4 Imm 0.73 
NEB (6) 1.00 1.40 1.08±0.16     
½ Imm (7) 1.00 1.41 1.07±0.15 NEB vs Imm gps 0.32 NS NS 
2 Imm (5) 1.00 1.69 1.24±0.27     




4 Imm (6) 1.00 1.58 1.26±0.27     
 
 




BCC: bone cell count   Imm: immediate replantation 
BIS: bone intensity score  NEB: non-experimental bone 
                                                            NS: Not Significant 
*: Statistically significant 
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NEC (6) 67.20 100 75.96+13.82     
½ Del (8) 71.01 93.64 85.20+8.08 NEC vs Del gps 0.17          NS           NS 
2 Del (8) 60.96 98.33 83.92+13.70     




4 Del (5) 57.38 97.74 78.85+15.63     
NEC (6) 1.05 0.86±0.16   NE vs ½ Del *0.01 
½ Del (8) 0.92 1.83 1.14±0.19 NEC vs Del gps     *0.04 NE vs 2 Del *0.01 
2 Del (8) 0.96 2.57 1.51±0.62   NE vs 3Del *0.00 
3 Del (8) 1.00 1.90 1.21±0.30 Del gps 0.91 NE vs 4Del  0.05 
4 Del (5) 1.00 1.60 1.17±0.25   ½ vs 2 Del 0.57 
      ½ vs 3 Del 0.96 
      ½ vs 4 Del  1.00 
      2vs 3 Del  0.80 





      3 vs 4 Del  0.62 
0.67 




CCC: cementum cell count   Del: delayed replantation 
CIS: cementum intensity score  NEC: non-experimental cementum 
                                                                        NS: Not Significant  
















NEP (6) 61.67 100 87.28+18.24   
½ Del (8) 73.32 98.13 88.23+10.12 NEP vs Del gps 0.82 
2 Del (8) 75.00 100 90.39+10.13   




4 Del (5) 76.60 100 87.58+12.16   
NEP (6) 0.92 1.60 1.12±0.25   
½ Del (8) 0.78 1.15 1.03±0.12 NEP vs Del gps 0.23 
2 Del (8) 1.06 1.66 1.43±0.47   













PCC: PDL cell count   Del: delayed replantation 



















NEB (6) 62.63 92.26 73.80±11.17   
½ Del (8) 63.34 83.36 71.11±6.89 NEB vs Del gps 0.30 
2 Del (8) 51.00 97.20 71.20±14.93   




4 Del (5) 72.77 99.79 87.11±13.04   
NEB (6) 1.00 1.40 1.08±0.16   
½ Del (8) 1.00 1.33 1.16±0.14 NEB vs Del gps 0.43 
2 Del (8) 1.00 1.83 1.24±0.29   













BCC: bone cell count   Del: delayed replantation 























½ Imm vs Del 0.87 0.46          *0.02 0.28 0.15 0.23 
2 Imm vs Del 1.00      0.94 0.25 0.83 0.44 1.00
3 Imm vs Del 0.90      0.83 0.53 0.11 0.55 0.84







CCC: cementum cell count  PCC: PDL cell count  BCC: bone cell count 
 















Table 9: Statistical comparison of percentage of positive cell count at different structures at each time group.  
 
Variable Treatment group Kruskal-Wallis (P≤0.05) Variable Groups Mann-Whitney (P≤ 0.02) 
0.52   NA NA
 
NE 
   
 CCC vs PCC *0.01 
                *0.00 CCC vs BCC *0.00 
 
½ Imm 
 PCC vs BCC *0.00 
 CCC vs PCC 0.34 
*0.00 CCC vs BCC *0.00 
 
½ Del 
 PCC vs BCC *0.01 
 CCC vs PCC 0.06 
*0.00 CCC vs BCC *0.01 
 
2 Imm 
 PCC vs BCC *0.01 
0.06   NA NA
 
2 Del 
   
 CCC vs PCC 0.04 
*0.00 CCC vs BCC *0.01 
 
3 Imm 
 PCC vs BCC *0.00 
 CCC vs PCC 0.76 
*0.05 CCC vs BCC 0.03 
 
3 Del 
 PCC vs BCC 0.06 
 CCC vs PCC 0.41 
*0.05 CCC vs BCC 0.08 
 
4 Imm 
 PCC vs BCC 0.04 


















   
   
   
   
*: Statistically significant                                         NA: Not Significant  
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 Table 10: Statistical comparison of intensity score in different structures at each time group. 
 
Variable Treatment group Kruskal-Wallis (P≤0.05) 
NE  0.07
½ Imm 0.44 
½ Del 0.26 
2 Imm 0.95 
2 Del 0.50 
3 Imm 0.46 
3 Del 0.76 












Comparison of percentage of positive cell count in cementum, bone and PDL in both 






























































































































































































































































- 0.01                  -   0.02                -   0.00 
 
     
      
 
       CCC - Cementum Cell Count 
       PCC - PDL Cell Count 
       BCC - Bone Cell count 
       NE   - Non-experimental group 
 
 
Imm – Immediate Replantation Group            














Comparison of extracellular matrix intensity in cementum, bone and PDL in both 




















































































































































































































  CIS- Cementum Intensity Score 
  PIS- PDL intensity Score 
  BIS- Bone Intensity Score 
  NE- Non-Experimental group 
 
  Imm – Immediate Replantation Group          
  Del – Delayed Replantation Group                                                                     
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